<SEC-DOCUMENT>0001193125-19-241995.txt : 20190910
<SEC-HEADER>0001193125-19-241995.hdr.sgml : 20190910
<ACCEPTANCE-DATETIME>20190910160804
ACCESSION NUMBER:		0001193125-19-241995
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20190905
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190910
DATE AS OF CHANGE:		20190910

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			iRhythm Technologies, Inc.
		CENTRAL INDEX KEY:			0001388658
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				208149544
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37918
		FILM NUMBER:		191085424

	BUSINESS ADDRESS:	
		STREET 1:		650 TOWNSEND STREET
		STREET 2:		SUITE 500
		CITY:			San Francisco
		STATE:			CA
		ZIP:			94103
		BUSINESS PHONE:		415-632-5700

	MAIL ADDRESS:	
		STREET 1:		650 TOWNSEND STREET
		STREET 2:		SUITE 500
		CITY:			San Francisco
		STATE:			CA
		ZIP:			94103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IRhythm Technologies, Inc.
		DATE OF NAME CHANGE:	20110429

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IRhythm Technologies Inc
		DATE OF NAME CHANGE:	20070201
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d765496d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:irtc="http://www.irhythmtech.com/20190905" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Form 8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2019-09-05_to_2019-09-05">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2019-09-05_to_2019-09-05">0001388658</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="irtc-20190905.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2019-09-05_to_2019-09-05"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001388658</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2019-09-05</xbrli:startDate> <xbrli:endDate>2019-09-05</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="font-size:10pt;width:8.5in;margin:0 auto"> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <p style="margin-bottom:0px;margin-top:4pt"></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">UNITED STATES</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">SECURITIES AND EXCHANGE COMMISSION</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Washington, D.C. 20549</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:10pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0px;margin-top:10pt">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2019-09-05_to_2019-09-05">8-K</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:10pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:10pt">CURRENT REPORT</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Pursuant to Section&#160;13 or 15(d)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">of the Securities Exchange Act of 1934</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:10pt">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2019-09-05_to_2019-09-05" format="ixt:datemonthdayyearen">September&#160;5, 2019</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:10pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:24pt;margin-bottom:0px;margin-top:10pt"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2019-09-05_to_2019-09-05">iRhythm Technologies, Inc.</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">(Exact name of Registrant as specified in its charter)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:10pt;margin-bottom:0px">&#160;</p></div>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:10pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2019-09-05_to_2019-09-05" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2019-09-05_to_2019-09-05">001-37918</ix:nonNumeric> </span></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2019-09-05_to_2019-09-05">20-8149544</ix:nonNumeric> </span></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(State or other jurisdiction of</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">incorporation or organization)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Commission</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">File Number)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(I.R.S. Employer</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Identification Number)</p></td></tr></table> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:10pt"> <ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2019-09-05_to_2019-09-05">650 Townsend Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2019-09-05_to_2019-09-05">Suite 500</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2019-09-05_to_2019-09-05">San Francisco</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2019-09-05_to_2019-09-05" format="ixt-sec:stateprovnameen">California</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2019-09-05_to_2019-09-05">94103</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Address of principal executive office) (Zip Code)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:10pt"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2019-09-05_to_2019-09-05">(415)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2019-09-05_to_2019-09-05">632-5700</ix:nonNumeric> </span></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Registrant&#8217;s telephone number, including area code)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:10pt">N/A</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Former Name or Former Address, if Changed Since Last Report)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:10pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:10pt">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2019-09-05_to_2019-09-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2019-09-05_to_2019-09-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2019-09-05_to_2019-09-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b)) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2019-09-05_to_2019-09-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c)) </span></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:10pt">Securities registered pursuant to Section&#160;12(b) of the Act:</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:10pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Title of each class</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Trading</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Symbol</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Name of each exchange</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">on which registered</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2019-09-05_to_2019-09-05">Common Stock, Par Value $.0001 Per Share</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2019-09-05_to_2019-09-05">IRTC</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2019-09-05_to_2019-09-05" format="ixt-sec:exchnameen">The NASDAQ Global Select Market</ix:nonNumeric></p></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:10pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167;&#160;<span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="font-family:Times New Roman;margin-left:0%;text-align:left;text-indent:0%;font-size:10pt;margin-bottom:0px;margin-top:10pt">Emerging growth company&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2019-09-05_to_2019-09-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:10pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal">&#9744;</span></p> <p style="margin-bottom:0px;margin-top:10pt"></p> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <div></div> <p style="margin-top:0"></p></div>

<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <div style="font-size:10pt;width:8.5in;margin:0 auto">
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;1.01. </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Entry into a Material Definitive Agreement</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">On September&#160;10, 2019, iRhythm Technologies, Inc. (the &#8220;Company&#8221;) issued and sold an aggregate of 1,575,342 shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), pursuant to an underwriting agreement dated September&#160;5, 2019 (the &#8220;Underwriting Agreement&#8221;) by and among the Company and J.P. Morgan Securities LLC and Morgan Stanley&#160;&#038; Co. LLC, as representatives of the several underwriters named therein (the &#8220;Underwriters&#8221;). The Shares include the full exercise of the Underwriters&#8217; option to purchase an additional 205,479 shares of Common Stock pursuant to the Underwriting Agreement. The Shares were sold in a public offering (the &#8220;Offering&#8221;) pursuant to a Registration Statement on Form <span style="white-space:nowrap">S-3</span> (File No.<span style="white-space:nowrap">&#160;333-</span> 233619) (the &#8220;Registration Statement&#8221;) and a related prospectus and prospectus supplement, in each case filed with the Securities and Exchange Commission. The Company received net proceeds from the Offering of approximately $107.35&#160;million, after deducting underwriting discounts and commissions and estimated offering expenses. The description of the Underwriting Agreement set forth above is qualified in its entirety by reference to the Underwriting Agreement, a copy of which is filed as Exhibit 1.1 hereto and is incorporated herein by reference. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">A copy of the opinion of Wilson Sonsini Goodrich&#160;&#038; Rosati, P.C relating to the validity of the Shares is filed as Exhibit 5.1 hereto and is incorporated by reference into the Registration Statement.&#160;</p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;9.01. </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Financial Statements and Exhibits.</td> </tr> </table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;">(d) </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Exhibits.</td> </tr> </table>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td></td>
<td></td>
<td></td>
<td style="width:5%;"></td>
<td style="width:92%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td colspan="2" style="white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Exhibit <br /><span style="text-decoration:underline">&#160;&#160;&#160;&#160;No.&#160;&#160;&#160;&#160;</span></p> </td>
<td style="white-space:nowrap;vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt"> <span style="text-decoration:underline">Description</span> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;1.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d765496dex11.htm">Underwriting Agreement by and among iRhythm Technologies, Inc. and J.P. Morgan Securities LLC and Morgan Stanley&#160;&#038; Co. LLC as representatives of the several underwriters named therein, dated September&#160;5, 2019. </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;5.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d765496dex51.htm">Opinion of Wilson Sonsini Goodrich&#160;&#038; Rosati, P.C. </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">23.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d765496dex51.htm">Consent of Wilson Sonsini Goodrich&#160;&#038; Rosati, P.C. (included in Exhibit 5.1) </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">104</p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</p> </td> </tr> </table> <div></div> <p style="margin-top:0"></p>
 </div>



<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="font-weight:Bold;font-style:normal">SIGNATURES</span> </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:0px;margin-right:auto">
<tr>
<td style="width:46%;"></td>
<td style="width:1%;"></td>
<td style="width:4%;"></td>
<td></td>
<td style="width:2%;"></td>
<td style="width:1%;"></td>
<td style="width:45%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td colspan="3" style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">IRHYTHM TECHNOLOGIES, INC. </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Date: September&#160;10, 2019 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">By: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;margin-bottom:1pt;font-size:10pt;margin-top:0pt;border-bottom:1px solid #000000">/s/ Kevin M. King </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Kevin M. King </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Chief Executive Officer </p> </td> </tr> </table> <div></div> <p style="margin-top:0"></p>
 </div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d765496dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>EXECUTION VERSION </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iRhythm
Technologies, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1,369,863 Shares of Common Stock </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Underwriting Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">September&nbsp;5, 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities
LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As Representatives
of the </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">several Underwriters listed </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in Schedule 1 hereto
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o J.P. Morgan Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">383 Madison Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10179 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Morgan Stanley&nbsp;&amp; Co. LLC
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1585 Broadway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10036 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">iRhythm Technologies,
Inc., a Delaware corporation (the &#147;Company&#148;), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the &#147;Underwriters&#148;), for whom you are acting as representatives (the &#147;Representatives&#148;),
an aggregate of 1,369,863 shares of common stock, par value $0.001 per share, of the Company (the &#147;Underwritten Shares&#148;) and, at the option of the Underwriters, up to an additional 205,479 shares of common stock of the Company (the
&#147;Option Shares&#148;). The Underwritten Shares and the Option Shares are herein referred to as the &#147;Shares&#148;. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to
herein as the &#147;Stock&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company hereby confirms its agreement with the several Underwriters concerning the purchase and sale
of the Shares, as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Registration Statement</U>. The Company has prepared and filed with the Securities and Exchange
Commission (the &#147;Commission&#148;) under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#147;Securities Act&#148;), a registration statement (File No.&nbsp;333-233619),
including a prospectus, relating to the Shares. Such registration statement, as amended at the time it became effective, including the information, if any, deemed pursuant to Rule 430A, 430B or 430C under the Securities Act to be part of the
registration statement at the time of its effectiveness (&#147;Rule 430 Information&#148;), is referred to herein as the &#147;Registration Statement&#148;; and as used herein, the term &#147;Preliminary Prospectus&#148; means each prospectus
included in such registration statement (and any amendments </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereto) before effectiveness, any prospectus filed with the Commission pursuant to Rule 424(a) under the Securities Act and the prospectus included in the Registration Statement at the time of
its effectiveness that omits Rule 430 Information, and the term &#147;Prospectus&#148; means the prospectus in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with
confirmation of sales of the Shares. If the Company has filed an abbreviated registration statement pursuant to Rule 462(b) under the Securities Act (the &#147;Rule 462 Registration Statement&#148;), then any reference herein to the term
&#147;Registration Statement&#148; shall be deemed to include such Rule 462 Registration Statement. Any reference in this underwriting agreement (this &#147;Agreement&#148;) to the Registration Statement, any Preliminary Prospectus or the Prospectus
shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item&nbsp;12 of Form S-3 under the Securities Act, as of the effective date of the Registration Statement or the date of such Preliminary Prospectus
or the Prospectus, as the case may be, and any reference to &#147;amend&#148;, &#147;amendment&#148; or &#147;supplement&#148; with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and
include any documents filed after such date under the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#147;Exchange Act&#148;) that are deemed to be incorporated by
reference therein. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Registration Statement and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At or prior to the Applicable Time (as defined below), the Company had prepared the following information (collectively with the pricing
information set forth on Annex A, the &#147;Pricing Disclosure Package&#148;): a Preliminary Prospectus dated September&nbsp;4, 2019 and each &#147;free-writing prospectus&#148; (as defined pursuant to Rule 405 under the Securities Act) listed on
Annex A hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Applicable Time&#148; means 5:20 P.M., New York City time, on September&nbsp;5, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Purchase of the Shares</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company agrees to issue and sell the Underwritten Shares to the several Underwriters as provided in this underwriting agreement (this
&#147;Agreement&#148;), and each Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase at a price per share of
$68.62 (the &#147;Purchase Price&#148;) from the Company the respective number of Underwritten Shares set forth opposite such Underwriter&#146;s name in Schedule 1 hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Company agrees to issue and sell the Option Shares to the several Underwriters as provided in this Agreement, and the
Underwriters, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, shall have the option to purchase, severally and not jointly, from the Company the Option Shares at the
Purchase Price less an amount per share equal to any dividends or distributions declared by the Company and payable on the Underwritten Shares but not payable on the Option Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Option Shares are to be purchased, the number of Option Shares to be purchased by each Underwriter shall be the number of Option Shares
which bears the same ratio to the aggregate number of Option Shares being purchased as the number of Underwritten Shares set forth opposite the name of such Underwriter in Schedule 1 hereto (or such number increased as set forth in Section&nbsp;10
hereof) bears to the aggregate number of Underwritten Shares being purchased from the Company by the several Underwriters, subject, however, to such adjustments to eliminate any fractional Shares as the Representatives in their sole discretion shall
make. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Underwriters may exercise the option to purchase Option Shares at any time in whole, or
from time to time in part, on or before the thirtieth day following the date of the Prospectus, by written notice from the Representatives to the Company. Such notice shall set forth the aggregate number of Option Shares as to which the option is
being exercised and the date and time when the Option Shares are to be delivered and paid for, which may be the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the Closing Date nor later than the tenth
full business day (as hereinafter defined) after the date of such notice (unless such time and date are postponed in accordance with the provisions of Section&nbsp;10 hereof). Any such notice shall be given at least two business days prior to the
date and time of delivery specified therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Company understands that the Underwriters intend to make a public offering of the
Shares, and initially to offer the Shares on the terms set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriters may offer and sell Shares to or through any affiliate of an Underwriter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Payment for the Shares shall be made by wire transfer in immediately available funds to the account specified by the Company to the
Representatives in the case of the Underwritten Shares, at the offices of Davis Polk&nbsp;&amp; Wardwell LLP, 1600 El Camino Real, Menlo Park, California 94025 at 10:00 A.M. New York City time on September&nbsp;10, 2019, or at such other time or
place on the same or such other date, not later than the fifth business day thereafter, as the Representatives and the Company may agree upon in writing or, in the case of the Option Shares, on the date and at the time and place specified by the
Representatives in the written notice of the Underwriters&#146; election to purchase such Option Shares. The time and date of such payment for the Underwritten Shares is referred to herein as the &#147;Closing Date&#148;, and the time and date for
such payment for the Option Shares, if other than the Closing Date, is herein referred to as the &#147;Additional Closing Date&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment for the Shares to be purchased on the Closing Date or the Additional Closing Date, as the case may be, shall be made against delivery
to the Representatives for the respective accounts of the several Underwriters of the Shares to be purchased on such date or the Additional Closing Date, as the case may be, with any transfer taxes payable in connection with the sale of such Shares
duly paid by the Company. Delivery of the Shares shall be made through the facilities of The Depository Trust Company (&#147;DTC&#148;) unless the Representatives shall otherwise instruct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company acknowledges and agrees that the Representatives and the other Underwriters are acting solely in the capacity of an arm&#146;s
length contractual counterparty to the Company with respect to the offering of Shares contemplated hereby (including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the
Company or any other person. Additionally, neither the Representatives nor any other Underwriter is advising the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall
consult with its own </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and neither the Representatives nor
the other Underwriters shall have any responsibility or liability to the Company with respect thereto. Any review by the Representatives and the other Underwriters of the Company, the transactions contemplated hereby or other matters relating to
such transactions will be performed solely for the benefit of the Underwriters and shall not be on behalf of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.
<U>Representations and Warranties of the Company</U>. The Company represents and warrants to each Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
<I>Preliminary Prospectus.</I> No order preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and each Preliminary Prospectus included in the Pricing Disclosure Package, at the time of filing thereof,
complied in all material respects with the Securities Act, and no Preliminary Prospectus, at the time of filing thereof, contained any untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with
information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in any Preliminary Prospectus, it being understood and agreed that the only such information furnished by
any Underwriter consists of the information described as such in Section&nbsp;7(b) hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Pricing Disclosure
Package</I>. The Pricing Disclosure Package as of the Applicable Time did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or
omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in such Pricing Disclosure Package, it being
understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section&nbsp;7(b) hereof. No statement of material fact included in the Prospectus has been omitted from the Pricing
Disclosure Package and no statement of material fact included in the Pricing Disclosure Package that is required to be included in the Prospectus has been omitted therefrom. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Issuer Free Writing Prospectus. </I>Other than the Registration Statement, the Preliminary Prospectus and the
Prospectus, the Company (including its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer
to any &#147;written communication&#148; (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Shares (each such communication by the Company or its agents and representatives
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
(other than a communication referred to in clause (i)&nbsp;below) an &#147;Issuer Free Writing Prospectus&#148;) other than (i)&nbsp;any document not constituting a prospectus pursuant to
Section&nbsp;2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act or (ii)&nbsp;the documents listed on Annex A hereto, each electronic road show and any other written communications approved in writing in advance by the
Representatives. Each such Issuer Free Writing Prospectus complies in all material respects with the Securities Act, has been or will be (within the time period specified in Rule 433) filed in accordance with the Securities Act (to the extent
required thereby) and does not conflict with the information contained in the Registration Statement or the Pricing Disclosure Package, and, when taken together with the Preliminary Prospectus accompanying, or delivered prior to delivery of, such
Issuer Free Writing Prospectus, did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in each such Issuer Free Writing
Prospectus or Preliminary Prospectus in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in such Issuer Free Writing
Prospectus or Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section&nbsp;7(b) hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Registration Statement and Prospectus.</I> The Registration Statement is an &#147;automatic shelf registration
statement&#148; as defined under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice of objection of the Commission to the use of such registration statement or
any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No order suspending the effectiveness of the Registration Statement has been issued by the Commission, and no proceeding for
that purpose or pursuant to Section&nbsp;8A of the Securities Act against the Company or related to the offering of the Shares has been initiated or threatened by the Commission; as of the applicable effective date of the Registration Statement and
any post-effective amendment thereto, the Registration Statement and any such post-effective amendment complied and will comply in all material respects with the Securities Act, and did not and will not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading; and as of the date of the Prospectus and any amendment or supplement thereto and as of the Closing Date and as
of the Additional Closing Date, as the case may be, the Prospectus will comply in all material respects with the Securities Act and will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in
conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration Statement and the Prospectus and any amendment or supplement thereto,
it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section&nbsp;7(b) hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Incorporated Documents.</I> The documents incorporated by reference
in the Registration Statement, the Prospectus and the Pricing Disclosure Package, when they were filed with the Commission conformed in all material respects to the requirements of the Exchange Act, and none of such documents contained any untrue
statement of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and any further documents so filed and incorporated by reference
in the Registration Statement, the Prospectus or the Pricing Disclosure Package, when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and will not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Financial Statements.</I> The financial statements (including the related notes thereto) of the Company and its
consolidated subsidiaries included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus comply in all material respects with the applicable requirements of the Securities Act and the Exchange
Act, as applicable, and present fairly, in all material respects, the financial position of the Company and its consolidated subsidiaries as of the dates indicated and the results of their operations and the changes in their cash flows for the
periods specified; such financial statements have been prepared in all material respects in conformity with generally accepted accounting principles (&#147;GAAP&#148;) in the United States applied on a consistent basis throughout the periods covered
thereby, and any supporting schedules included or incorporated by reference in the Registration Statement present fairly, in all material respects, the information required to be stated therein; the other financial information included or
incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus has been derived from the accounting records of the Company and its consolidated subsidiaries and presents fairly, in all material respects,
the information shown thereby all disclosures included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus regarding &#147;non-GAAP financial measures&#148; (as such term is defined by the
rules and regulations of Commission) comply with Regulation G of the Exchange Act and Item&nbsp;10 of Regulation S-K of the Securities Act, to the extent applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>No Material Adverse Change.</I> Since the date of the most recent financial statements of the Company included or
incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (i)&nbsp;there has not been any change in the capital stock (other than the issuance of shares of Stock upon exercise of stock options and
warrants described as outstanding in, and the grant of options and awards under existing equity incentive plans described in, the Registration Statement, the Pricing Disclosure Package and the Prospectus), short-term debt or long-term debt of the
Company or any of its subsidiaries, or any dividend or distribution of any kind declared, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
set aside for payment, paid or made by the Company on any class of capital stock, or any material adverse change, or any development involving a prospective material adverse change, in or
affecting the business, properties, management, financial position, stockholders&#146; equity, results of operations or prospects of the Company and its subsidiaries taken as a whole; (ii)&nbsp;neither the Company nor any of its subsidiaries has
entered into any transaction or agreement (whether or not in the ordinary course of business) that is material to the Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or contingent, that is material to
the Company and its subsidiaries taken as a whole; and (iii)&nbsp;neither the Company nor any of its subsidiaries has sustained any loss or interference with its business that is material to the Company and its subsidiaries taken as a whole and that
is either from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority, except in each
case as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)
<I>Organization and Good Standing.</I> The Company and each of its subsidiaries have been duly organized and are duly incorporated and validly existing and in good standing under the laws of their respective jurisdictions of organization, are duly
qualified to do business and are in good standing in each jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such qualification, and have all power and authority necessary to
own or lease their respective properties and to conduct the businesses in which they are engaged, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a
material adverse effect on the business, properties, management, financial position, stockholders&#146; equity, results of operations or prospects of the Company and its subsidiaries taken as a whole or on the performance by the Company of its
obligations under this Agreement (a &#147;Material Adverse Effect&#148;). The Company does not have any significant subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Capitalization.</I> The Company has an authorized capitalization as set forth in the Registration Statement, the Pricing
Disclosure Package and the Prospectus under the heading &#147;Description of Capital Stock&#148;; all the outstanding shares of capital stock of the Company have been duly and validly authorized and issued and are fully paid and non-assessable and
are not subject to any pre-emptive or similar rights; except as described in or expressly contemplated by the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no outstanding rights (including, without limitation,
pre-emptive rights), warrants or options to acquire, or instruments convertible into or exchangeable for, any shares of capital stock or other equity interest in the Company or any of its subsidiaries, or any contract, commitment, agreement,
understanding or arrangement of any kind relating to the issuance of any capital stock of the Company or any such subsidiary, any such convertible or exchangeable securities or any such rights, warrants or options; the capital stock of the Company
conforms in all material respects to the description thereof contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus; and all the outstanding shares of capital stock or other equity interests of each subsidiary
owned, directly or indirectly, by the Company have been duly and validly authorized and issued, are fully paid and non-assessable and are owned directly or indirectly by the Company, free and clear of any lien, charge, encumbrance, security
interest, restriction on voting or transfer or any other claim of any third party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Stock Options. </I>With respect to the stock options (the &#147;Stock
Options&#148;) granted pursuant to the stock-based compensation plans of the Company and its subsidiaries (the &#147;Company Stock Plans&#148;), (i)&nbsp;each Stock Option intended to qualify as an &#147;incentive stock option&#148; under
Section&nbsp;422 of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), so qualifies, (ii)&nbsp;each grant of a Stock Option was duly authorized no later than the date on which the grant of such Stock Option was by its terms to be
effective by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee thereof) and any required stockholder approval by the necessary number of votes
or written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto, (iii)&nbsp;each such grant was made in all material respects in accordance with the terms of the Company Stock Plans,
the Exchange Act and all other applicable laws and regulatory rules or requirements, including the rules of the Nasdaq Global Select Market, and (iv)&nbsp;each such grant was properly accounted for in accordance with GAAP in the financial statements
(including the related notes) of the Company and disclosed in the Company&#146;s filings with the Commission in accordance with the Exchange Act and all other applicable laws. The Company has not knowingly granted, and there is no and has been no
policy or practice of the Company of granting, Stock Options prior to, or otherwise coordinating the grant of Stock Options with, the release or other public announcement of material information regarding the Company or its subsidiaries or their
results of operations or prospects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Due Authorization.</I> The Company has full right, power and authority to
execute and deliver this Agreement and to perform its obligations hereunder; and all action required to be taken for the due and proper authorization, execution and delivery by it of this Agreement and the consummation by it of the transactions
contemplated hereby has been duly and validly taken. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Underwriting Agreement. </I>This Agreement has been duly
authorized, executed and delivered by the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>The Shares. </I>The Shares to be issued and sold by the Company
hereunder have been duly authorized by the Company and, when issued and delivered and paid for as provided herein, will be duly and validly issued, will be fully paid and nonassessable and will conform to the descriptions thereof in the Registration
Statement, the Pricing Disclosure Package and the Prospectus; and the issuance of the Shares is not subject to any preemptive or similar rights. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>Description of the Underwriting Agreement.</I> This Agreement conforms in all material respects to the description
thereof contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <I>No Violation or Default.</I> Neither the Company nor any of its
subsidiaries is (i)&nbsp;in violation of its charter or by-laws or similar organizational documents; (ii)&nbsp;in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance
or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any property or asset of the Company or any of its subsidiaries is subject; or (iii)&nbsp;in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or
regulatory authority, except, in the case of clauses (ii)&nbsp;and (iii)&nbsp;above, for any such default or violation that would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <I>No Conflicts. </I>The execution, delivery and performance by the Company of this Agreement, the issuance and sale of the
Shares and the consummation of the transactions contemplated by this Agreement or the Pricing Disclosure Package and the Prospectus will not (i)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions of, or
constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any property, right or asset of the Company or any of its subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan agreement or
other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any property, right or asset of the Company or any of its subsidiaries is subject,
(ii)&nbsp;result in any violation of the provisions of the charter or by-laws or similar organizational documents of the Company or any of its subsidiaries or (iii)&nbsp;result in the violation of any law or statute or any judgment, order, rule or
regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (i)&nbsp;and (iii)&nbsp;above, for any such conflict, breach, violation, default, lien, charge or encumbrance that would not, individually
or in the aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) <I>No Consents Required.</I> No consent, approval, authorization,
order, registration or qualification of or with any court or arbitrator or governmental or regulatory authority is required for the execution, delivery and performance by the Company of this Agreement, the issuance and sale of the Shares and the
consummation of the transactions contemplated by this Agreement, except for the registration of the Shares under the Securities Act and such consents, approvals, authorizations, orders and registrations or qualifications as may be required by the
Financial Industry Regulatory Authority, Inc. (&#147;FINRA&#148;), the NASDAQ Stock Market and under applicable state securities laws in connection with the purchase and distribution of the Shares by the Underwriters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) <I>Legal Proceedings.</I> Except as described in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, there are no legal, governmental or regulatory investigations, actions, suits or enforcement proceedings (&#147;Actions&#148;) pending to which the Company or any of its subsidiaries is or may be a party or to which any property of the
Company or any of its subsidiaries is or may be the subject that, individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect; no such Actions are threatened or, to the knowledge of the Company,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
contemplated by any governmental or regulatory authority or threatened by others; and (i)&nbsp;there are no current or pending Actions that are required under the Securities Act to be described
in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and (ii)&nbsp;there are no statutes, regulations or contracts
or other documents that are required under the Securities Act to be filed as exhibits to the Registration Statement or described in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so filed as exhibits to the
Registration Statement or described in the Registration Statement, the Pricing Disclosure Package and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s)
<I>Independent Accountants</I>. PricewaterhouseCoopers LLP, who have certified certain financial statements of the Company and its subsidiaries, is an independent registered public accounting firm with respect to the Company and its subsidiaries
within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) <I>Title to Real and Personal Property</I>. The Company and its subsidiaries have good and marketable title in fee simple
(in the case of real property) to, or have valid and marketable rights to lease or otherwise use, all items of real and personal property and assets that are material to the respective businesses of the Company and its subsidiaries, in each case
free and clear of all liens, encumbrances, claims and defects and imperfections of title except those that (i)&nbsp;do not materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries or
(ii)&nbsp;could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u)
<I>Intellectual Property.</I> Except for specific matters the Company is aware of that are accurately described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, and except as would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect, the Company owns, licenses, otherwise possesses, or can promptly acquire on commercially reasonable terms, adequate rights to use all inventions, patents, trademarks, service
marks, trade names, domain names, copyrights, licenses, technology, know-how, trade secrets and other intellectual property and proprietary or confidential information, systems or procedures (including all goodwill associated with, and all
registrations and applications for registration of, the foregoing) (collectively, &#147;Intellectual Property&#148;) necessary for or material to the conduct of its businesses as currently conducted and as proposed in the Registration Statement, the
Pricing Disclosure Package and the Prospectus to be conducted by it. Except for specific matters the Company is aware of that are accurately described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the conduct of
the business of the Company, has not infringed, misappropriated or otherwise violated any Intellectual Property of others in any material respect, and to the knowledge of the Company, the conduct of the business of the Company as proposed in the
Registration Statement, the Pricing Disclosure Package and the Prospectus to be conducted by it will not infringe, misappropriate or otherwise violate the Intellectual Property of others in any material respect. Except as disclosed in the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Registration Statement, the Pricing Disclosure Package and the Prospectus, and except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect,
there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim (i)&nbsp;challenging the Company&#146;s rights in or to, or alleging the violation of any of the terms of, any of its Intellectual Property;
(ii)&nbsp;alleging that the Company has infringed, misappropriated or otherwise violated or conflicted with any Intellectual Property of any third party; or (iii)&nbsp;challenging the validity, scope or enforceability of any Intellectual Property
owned by or exclusively or co-exclusively licensed to the Company. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus or as would not reasonably be expected, individually or in the aggregate, to have
a Material Adverse Effect, all Intellectual Property owned or licensed by the Company is, to the knowledge of the Company, valid and enforceable, is solely owned, licensed or co-licensed by the Company, is owned free and clear of all liens,
encumbrances, defects and other restrictions, and to the knowledge of the Company, no third party has infringed, misappropriated or otherwise violated any Intellectual Property owned by or exclusively or co-exclusively licensed to the Company. The
Company has at all times taken reasonable steps in accordance with normal industry practice to maintain the confidentiality of all Intellectual Property, the value of which to the Company is contingent upon maintaining the confidentiality thereof,
and no such Intellectual Property has been disclosed other than to employees, representatives, independent contractors, collaborators, licensors, licensees, agents and advisors of the Company, all of whom are bound by written obligations to maintain
the confidentiality thereof, except for disclosures that would not, individually or in the aggregate, have a Material Adverse Effect. To the knowledge of the Company, all founders, current and former employees, contractors, consultants and other
parties involved in the development of Intellectual Property for the Company have signed confidentiality and invention assignment agreements with the Company, pursuant to which the Company either (x)&nbsp;has obtained ownership of and is the
exclusive owner of such Intellectual Property, or (y)&nbsp;has obtained a valid right to exploit such Intellectual Property, sufficient for the conduct of its business as currently conducted and as proposed in the Registration Statement, the Pricing
Disclosure Package and the Prospectus to be conducted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <I>No Undisclosed Relationships</I>. No relationship, direct or
indirect, exists between or among the Company or any of its subsidiaries, on the one hand, and the directors, officers, stockholders, customers, suppliers or other affiliates of the Company or any of its subsidiaries, on the other, that is required
by the Securities Act to be described in each of the Registration Statement and the Prospectus and that is not so described in such documents and in the Pricing Disclosure Package. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) <I>Investment Company Act</I>. The Company is not and, after giving effect to the offering and sale of the Shares and the
application of the proceeds thereof as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, will not be required to register as an &#147;investment company&#148; or an entity &#147;controlled&#148; by an
&#147;investment company&#148; within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#147;Investment Company Act&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) <I>Taxes.</I> The Company and its subsidiaries have paid all federal,
state, local and foreign taxes and filed all tax returns required to be paid or filed through the date hereof, except where such failure to pay or file would not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect; and except as otherwise disclosed in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus or as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, there is
no tax deficiency that has been, or could reasonably be expected to be, asserted against the Company or any of its subsidiaries or any of their respective properties or assets. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) <I>Licenses and Permits</I>. The Company and its subsidiaries possess all licenses, certificates, permits and other
authorizations issued by, and have made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the
conduct of their respective businesses as now conducted or as proposed to be conducted, in each case as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, except where the failure to possess or make the same
would not, individually or in the aggregate, have a Material Adverse Effect; and except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor any of its subsidiaries has received
notice of any revocation or modification of any such license, certificate, permit or authorization or has any reason to believe that any such license, certificate, permit or authorization will not be renewed in the ordinary course. Except as
described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, as applicable, the Company and its subsidiaries (i)&nbsp;are, and at all times have been, except as would not, individually or in the aggregate, have a
Material Adverse Effect, in compliance with all statutes, rules and regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, storage, import, export or disposal of any product manufactured
or distributed by the Company or its subsidiaries, and other statutes, rules and regulations applicable to the Company or its subsidiaries, including any fraud and abuse, health care program exclusion, and privacy laws and regulations (collectively,
the &#147;Applicable Laws&#148;); and (ii)&nbsp;have not received any U.S. Food and Drug Administration (&#147;FDA&#148;) Form 483, written notice of adverse finding, warning letter, untitled letter or other correspondence or written notice from any
court or arbitrator or governmental or regulatory authority alleging or asserting non-compliance with (x)&nbsp;any Applicable Laws or (y)&nbsp;any licenses, exemptions, certificates, approvals, clearances, authorizations, permits and supplements or
amendments thereto required by any such Applicable Laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) <I>Regulatory Filings</I>. The Company has not failed to file
with the Regulatory Authorities any required filing, declaration, listing, registration, report or submission with respect to the Company&#146;s products and product candidates that are described or referred to in the Registration Statement, the
Pricing Disclosure Package and the Prospectus; all such filings, declarations, listings, registrations, reports or submissions were in material compliance with applicable laws when filed; and no material deficiencies regarding compliance with
applicable law have been asserted by any applicable regulatory authority with respect to any such filings, declarations, listings, registrations, reports or submissions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa) <I>Product Manufacturing</I>. The manufacture of the Company&#146;s
products by or, to the knowledge of the Company, on behalf of the Company is being conducted in compliance in all material respects with the Federal Food, Drug, and Cosmetic Act, including, without limitation, the FDA&#146;s Quality System
Regulation at 21 CFR Part 820, and, to the extent applicable, the respective counterparts thereof promulgated by governmental authorities in the United Kingdom and the European Union. Except as disclosed in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, the Company has not had any manufacturing site (whether Company-owned or, to the knowledge of the Company, that of a third-party manufacturer for the Company&#146;s products) subject to a governmental authority
(including FDA) shutdown or import or export prohibition. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb) <I>No Safety Notices</I>. Except as disclosed in the
Registration Statement, the Pricing Disclosure Package and the Prospectus, or as otherwise would not have a Material Adverse Effect, there have been no recalls, field notifications, field corrections, market withdrawals, &#147;dear doctor&#148;
letters, investigator notices, safety alerts or other notice of action relating to an alleged lack of safety, efficacy, or regulatory compliance of the Company&#146;s products (&#147;Safety Notices&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc) <I>Clinical Data and Regulatory Compliance</I>. The preclinical tests and clinical trials, and other studies conducted by
or at the direction or on behalf of the Company, or in which the Company or its subsidiaries have participated (collectively, &#147;Company Studies&#148;) that are described in, or the results of which are referred to in, the Registration Statement,
the Pricing Disclosure Package or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such Company Studies and with standard
medical and scientific research procedures and all applicable statutes and all applicable rules and regulations of the FDA and comparable regulatory agencies outside of the United States to which they are subject (collectively, the &#147;Regulatory
Authorities&#148;); each description of the Company Studies that are described in, or the results of which are referred to in, the Registration Statement, the Pricing Disclosure Package or the Prospectus, is, in all material respects, accurate and
fairly presents in all material respects the data derived from such Company Studies; each description of other preclinical tests and clinical trials and other studies conducted by third parties (collectively, the &#147;Third-Party Studies&#148;)
that are described in, or the results of which are referred to in, the Registration Statement, the Pricing Disclosure Package or the Prospectus, accurately and fairly presents in all material respects the published results of such Third-Party
Studies; to the knowledge of the Company, the Registration Statement, the Pricing Disclosure Package and the Prospectus, as of the Applicable Time, did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will
not, omit to state a material fact relating to any described preclinical tests and clinical trials, and other studies, necessary in order to make the statements relating to the Company Studies and Third-party Studies therein, in the light of the
circumstances under which they were made, not misleading; the Company and its subsidiaries have made all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
such filings and obtained all such authorizations, clearances or approvals as have been required by the FDA or from any other U.S. or foreign government medical device regulatory agency, or
health care facility Institutional Review Board (collectively, the &#147;Regulatory Agencies&#148;), with respect to all clinical trials conducted by the Company, except where the failure to make such filings or obtain such authorizations,
clearances or approvals would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and neither the Company nor its subsidiaries have received any written notice of, or correspondence from, any Regulatory
Agency requiring the termination, suspension or modification, other than any modification in the ordinary course, of any clinical trials that are described or referred to in the Registration Statement, the Pricing Disclosure Package or the
Prospectus, and, to the knowledge of the Company, there are no reasonable grounds for the same; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules and
regulations of the Regulatory Agencies. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd) <I>No Labor Disputes.</I> No labor disturbance by or dispute with employees
of the Company or any of its subsidiaries exists or, to the knowledge of the Company, is contemplated or threatened, and the Company is not aware of any existing or imminent labor disturbance by, or dispute with, the employees of any of its or its
subsidiaries&#146; principal suppliers, contractors or customers, except as would not have a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received any notice of cancellation or termination with respect to any
collective bargaining agreement to which it is a party. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee) <I>Certain Environmental Matters</I>. (i)&nbsp;The Company
and its subsidiaries (a)&nbsp;are, and at all prior times were, in compliance with any and all applicable federal, state, local and foreign laws, rules, regulations, requirements, decisions, judgments, decrees, orders and the common law relating to
pollution or the protection of the environment, natural resources or human health or safety, including those relating to the generation, storage, treatment, use, handling, transportation, Release or threat of Release of Hazardous Materials
(collectively, &#147;Environmental Laws&#148;), (b)&nbsp;have received and are in compliance with all permits, licenses, certificates or other authorizations or approvals required of them under applicable Environmental Laws to conduct their
respective businesses, (c)&nbsp;have not received notice of any actual or potential liability under or relating to, or actual or potential violation of, any Environmental Laws, including for the investigation or remediation of any Release or threat
of Release of Hazardous Materials, and have no knowledge of any event or condition that would reasonably be expected to result in any such notice, (d)&nbsp;are not conducting or paying for, in whole or in part, any investigation, remediation or
other corrective action pursuant to any Environmental Law at any location, and (e)&nbsp;are not a party to any order, decree or agreement that imposes any obligation or liability under any Environmental Law, and (ii)&nbsp;there are no costs or
liabilities associated with Environmental Laws of or relating to the Company or its subsidiaries, except in the case of each of (i)&nbsp;and (ii)&nbsp;above, for any such matter, as would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect; and (iii)&nbsp;except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (a)&nbsp;there are no proceedings that are pending, or that are
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
known to be contemplated, against the Company or any of its subsidiaries under any Environmental Laws in which a governmental entity is also a party, other than such proceedings regarding which
it is reasonably believed no monetary sanctions of $100,000 or more will be imposed, and (b)&nbsp;the Company and its subsidiaries are not aware of any facts or issues regarding compliance with Environmental Laws, or liabilities or other obligations
under Environmental Laws, including the Release or threat of Release of Hazardous Materials, that could reasonably be expected to have a material adverse effect on the capital expenditures, earnings or competitive position of the Company and its
subsidiaries, and (c)&nbsp;none of the Company and its subsidiaries anticipate material capital expenditures relating to any Environmental Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff) <I>Hazardous Materials</I>. There has been no storage, generation, transportation, use, handling, treatment, Release or
threat of Release of Hazardous Materials by, relating to or caused by the Company or any of its subsidiaries (or, to the knowledge of the Company and its subsidiaries, any other entity (including any predecessor) for whose acts or omissions the
Company or any of its subsidiaries is or could reasonably be expected to be liable) at, on, under or from any property or facility now or previously owned, operated or leased by the Company or any of its subsidiaries, or at, on, under or from any
other property or facility, in violation of any Environmental Laws or in a manner or amount or to a location that could reasonably be expected to result in any liability to the Company under any Environmental Law, except for any violation or
liability which would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. &#147;Hazardous Materials&#148; means any material, chemical, substance, waste, pollutant, contaminant, compound, mixture, or
constituent thereof, in any form or amount, including petroleum (including crude oil or any fraction thereof) and petroleum products, natural gas liquids, asbestos and asbestos containing materials, naturally occurring radioactive materials, brine,
and drilling mud, regulated or which can give rise to liability under any Environmental Law. &#147;Release&#148; means any spilling, leaking, seepage, pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching, dumping,
disposing, depositing, dispersing, or migrating in, into or through the environment, or in, into, from or through any building or structure. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg) <I>Compliance with ERISA</I>. (i)&nbsp;Each employee benefit plan, within the meaning of Section&nbsp;3(3) of the Employee
Retirement Income Security Act of 1974, as amended (&#147;ERISA&#148;), for which the Company or any member of its &#147;Controlled Group&#148; (defined as any organization which is a member of a controlled group of corporations within the meaning
of Section&nbsp;414 of the Code) would have any liability (each, a &#147;Plan&#148;) has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA
and the Code, except for noncompliance that could not reasonably be expected to result in material liability to the Company or its subsidiaries; (ii)&nbsp;no prohibited transaction, within the meaning of Section&nbsp;406 of ERISA or
Section&nbsp;4975 of the Code, has occurred with respect to any Plan excluding transactions effected pursuant to a statutory or administrative exemption that could reasonably be expected to result in a material liability to the Company or its
subsidiaries; (iii)&nbsp;for each Plan that is subject to the funding rules of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, the minimum funding standard of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, as applicable, has been satisfied (without taking into account any waiver thereof or extension of any amortization period) and is
reasonably expected to be satisfied in the future (without taking into account any waiver thereof or extension of any amortization period); (iv)&nbsp;the fair market value of the assets of each Plan that is a defined benefit plan with the meaning of
Section&nbsp;3(35) of ERISA (&#147;Pension Plan&#148;) exceeds the present value of all benefits accrued under such Pension Plan (determined based on those assumptions used to fund such Pension Plan); (v)&nbsp;no &#147;reportable event&#148; (within
the meaning of Section&nbsp;4043(c) of ERISA) has occurred or is reasonably expected to occur that either has resulted, or could reasonably be expected to result, in material liability to the Company or its subsidiaries; (vi)&nbsp;neither the
Company nor any member of the Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the PBGC, in the ordinary course and without default) in respect
of a Plan (including a &#147;multiemployer plan&#148;, within the meaning of Section&nbsp;4001(a)(3) of ERISA); and (vii)&nbsp;there is no pending audit or investigation by the Internal Revenue Service, the U.S. Department of Labor, the Pension
Benefit Guaranty Corporation or any other governmental agency or any foreign regulatory agency with respect to any Plan that could reasonably be expected to result in material liability to the Company or its subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh) <I>Disclosure Controls</I>. The Company and its subsidiaries maintain an effective system of &#147;disclosure controls and
procedures&#148; (as defined in Rule 13a-15(e) of the Exchange Act) that complies with the requirements of the Exchange Act and that has been designed to ensure that information required to be disclosed by the Company in reports that it files or
submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&#146;s rules and forms, including controls and procedures designed to ensure that such information is accumulated and
communicated to the Company&#146;s management as appropriate to allow timely decisions regarding required disclosure. The Company and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as
required by Rule 13a-15 of the Exchange Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>Accounting Controls.</I> The Company and its subsidiaries maintain
systems of &#147;internal control over financial reporting&#148; (as defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their respective
principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with GAAP. The Company and its subsidiaries maintain internal accounting controls sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations;
(ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general
or specific authorization; (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
differences and (v)&nbsp;interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement, the Prospectus and the Pricing Disclosure
Package fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. Based on the Company&#146;s most recent evaluation of its internal controls
over financial reporting pursuant to Rule 13a-15(c) of the Exchange Act, except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no material weaknesses in the Company&#146;s internal controls.
The Company&#146;s auditors and the Audit Committee of the Board of Directors of the Company have been advised of: (i)&nbsp;all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting
which have adversely affected or are reasonably likely to adversely affect the Company&#146;s ability to record, process, summarize and report financial information; and (ii)&nbsp;any fraud, whether or not material, that involves management or other
employees who have a significant role in the Company&#146;s internal controls over financial reporting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj) <I>eXtensible
Business Reporting Language.</I> The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement fairly presents the information called for in all material respects and has been
prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk) <I>Insurance. </I>The
Company and its subsidiaries have insurance covering their respective properties, operations, personnel and businesses, including business interruption insurance, which insurance is in amounts and insures against such losses and risks as the Company
reasonably believes are adequate to protect the Company and its subsidiaries and their respective businesses; and neither the Company nor any of its subsidiaries has (i)&nbsp;received notice from any insurer or agent of such insurer that capital
improvements or other expenditures are required or necessary to be made in order to continue such insurance or (ii)&nbsp;any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to
obtain similar coverage at reasonable cost from similar insurers as may be necessary to continue its business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll)
<I>Cybersecurity; Data Protection</I>. The Company and its subsidiaries&#146; information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &#147;IT Systems&#148;)
are adequate for, and operate and perform in all material respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted, and, to the knowledge of the Company, are free and clear of
all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company and its subsidiaries have implemented and maintained commercially reasonable information technology, information security, cyber security and
data protection controls, policies, procedures, and safeguards, including oversight, access controls, encryption, technological and physical safeguards and business continuity/disaster recovery and security plans, to maintain and protect their
material confidential information and the integrity, continuous operation, redundancy and security of, and to prevent the breach, destruction, loss, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
unauthorized distribution, use, access, disablement, misappropriation, modification or other misuse of (&#147;Breach&#148;), all IT Systems and data (including all personal, personally
identifiable, sensitive, confidential or regulated data and all data of their respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of the Company or its subsidiaries (&#147;Personal Data&#148;))
used in connection with their businesses. There have been no Breaches, violations, outages or unauthorized uses of or accesses to any IT Systems and Personal Data, except for those that have been remedied without material cost or liability or the
duty to notify any other person, nor any incidents under internal review or investigations relating to any such IT Systems and Personal Data. The Company and its subsidiaries are presently in material compliance with all applicable laws or statutes
and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the
protection of such IT Systems and Personal Data from any Breach (&#147;Privacy Laws&#148;). Neither the Company nor any of its subsidiaries has received notice of any actual or potential liability under or relating to, or actual or potential
violation of, any Privacy Laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm) <I>No Unlawful Payments.</I> Neither the Company nor any of its subsidiaries nor any
director, officer or employee of the Company or any of its subsidiaries nor, to the knowledge of the Company, any agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries has (i)&nbsp;used any
corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii)&nbsp;made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful
payment or benefit to any foreign or domestic government official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of
the foregoing, or any political party or party official or candidate for political office; (iii)&nbsp;violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or regulation
implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or
anti-corruption law; or (iv)&nbsp;made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any unlawful rebate, payoff, influence payment, kickback or other
unlawful or improper payment or benefit. The Company and its subsidiaries have instituted, maintain and enforce, and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable
anti-bribery and anti-corruption laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(nn) <I>Compliance with Anti-Money Laundering Laws</I>. The operations of the
Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the
applicable money laundering statutes of all jurisdictions where the Company or any of its subsidiaries conducts business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or
enforced by any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
governmental agency (collectively, the &#147;Anti-Money Laundering Laws&#148;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(oo) <I>No Conflicts with Sanctions Laws. </I>Neither the Company nor any of its subsidiaries, directors, officers, or
employees, nor, to the knowledge of the Company, any agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries is currently the subject or the target of any sanctions administered or enforced by
the U.S. government, (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#147;OFAC&#148;) or the U.S. Department of State and including, without limitation, the designation as a
&#147;specially designated national&#148; or &#147;blocked person&#148;), the United Nations Security Council (&#147;UNSC&#148;), the European Union, Her Majesty&#146;s Treasury (&#147;HMT&#148;) or other relevant sanctions authority (collectively,
&#147;Sanctions&#148;), nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or target of Sanctions, including, without limitation, Crimea, Cuba, Iran, North Korea and Syria
(each, a &#147;Sanctioned Country&#148;); and the Company will not directly or indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture
partner or other person or entity (i)&nbsp;to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is the subject or target of Sanctions, (ii)&nbsp;to fund or facilitate any activities
of or business in any Sanctioned Country or (iii)&nbsp;in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions.
For the past five years, the Company and its subsidiaries have not knowingly engaged in and are not now knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the
target of Sanctions or with any Sanctioned Country. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(pp) <I>No Restrictions on Subsidiaries</I>. No subsidiary of the
Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution on such subsidiary&#146;s capital
stock or similar ownership interest, from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary&#146;s properties or assets to the Company or any other subsidiary of the
Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(qq) <I>No Broker&#146;s Fees.</I> Neither the Company nor any of its subsidiaries is a party to any contract,
agreement or understanding with any person (other than this Agreement) that would give rise to a valid claim against any of them or any Underwriter for a brokerage commission, finder&#146;s fee or like payment in connection with the offering and
sale of the Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(rr) <I>No Registration Rights</I>. No person has the right to require the Company or any of its
subsidiaries to register any securities for sale under the Securities Act by reason of the filing of the Registration Statement with the Commission or the issuance and sale of the Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ss) <I>No Stabilization.</I> Neither the Company nor any of its
subsidiaries or affiliates has taken, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(tt) <I>Margin Rules</I>. The application of the proceeds received by the Company from the issuance, sale and delivery of the
Shares as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of
Governors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(uu) <I>Forward-Looking Statements.</I> No forward-looking statement (within the meaning of Section&nbsp;27A of
the Securities Act and Section&nbsp;21E of the Exchange Act) included or incorporated by reference in any of the Registration Statement, the Pricing Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable basis or has
been disclosed other than in good faith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vv) <I>Statistical and Market Data.</I> Nothing has come to the attention of the
Company that has caused the Company to believe that the statistical and market-related data included or incorporated by reference in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus is not based on or derived
from sources that are reliable and accurate in all material respects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ww) <I>Sarbanes-Oxley Act</I>. The Company, its
directors and its officers, in their capacities as such, have complied in all material respects with the provisions of the Sarbanes-Oxley Act of 2002, as amended and the rules and regulations promulgated in connection therewith (the
&#147;Sarbanes-Oxley Act&#148;), including Section&nbsp;402 related to loans and Sections 302 and 906 related to certifications. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xx) <I>Status under the Securities Act</I>. At the time of filing the Registration Statement and any post-effective amendment
thereto, at the earliest time thereafter that the Company or any offering participant made a <I>bona fide</I> offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the Shares and at the date hereof, the Company was not and is not
an &#147;ineligible issuer,&#148; and is a well-known seasoned issuer, in each case as defined in Rule 405 under the Securities Act. The Company has paid the registration fee for this offering pursuant to Rule 456(b)(1) under the Securities Act or
will pay such fee within the time period required by such rule (without giving effect to the proviso therein) and in any event prior to the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(yy) <I>No Ratings</I>. There are (and prior to the Closing Date, will be) no debt securities, convertible securities or
preferred stock issued or guaranteed by the Company or any of its subsidiaries that are rated by a &#147;nationally recognized statistical rating organization&#148;, as such term is defined in Section&nbsp;3(a)(62) under the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Further Agreements of the Company</U>. The Company covenants and agrees with each
Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Required Filings.</I> The Company will file the final Prospectus with the Commission within the
time periods specified by Rule 424(b) and Rule 430A, 430B or 430C under the Securities Act, will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the Securities Act; and the Company will file promptly all reports and
any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and during the Prospectus Delivery
Period; and the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously delivered) to the Underwriters in New York City prior to 10:00 A.M., New York City time, on the business day next
succeeding the date of this Agreement in such quantities as the Representatives may reasonably request. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Delivery of
Copies.</I> The Company will deliver, without charge, (i)&nbsp;to the Representatives, three signed copies of the Registration Statement as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith
and documents incorporated by reference therein; and (ii)&nbsp;to each Underwriter (A)&nbsp;a conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits) and (B)&nbsp;during the Prospectus Delivery
Period (as defined below), as many copies of the Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein and each Issuer Free Writing Prospectus) as the Representatives may reasonably request. As
used herein, the term &#147;Prospectus Delivery Period&#148; means such period of time after the first date of the public offering of the Shares to the earlier of: (i)&nbsp;the completion of the distribution of the Shares by the Underwriters or
(ii)&nbsp;as in the opinion of counsel for the Underwriters a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Shares by any
Underwriter or dealer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Amendments or Supplements, Issuer Free Writing Prospectuses.</I> Before making, preparing,
using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement, the Pricing Disclosure Package or the Prospectus, whether before or after the time
that the Registration Statement becomes effective, the Company will furnish to the Representatives and counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not make, prepare,
use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed amendment or supplement to which the Representatives reasonably objects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Notice to the Representatives.</I> The Company will advise the Representatives promptly, and confirm such advice in
writing, (i)&nbsp;when any amendment to the Registration Statement has been filed or becomes effective other than pursuant to the filing of the Preliminary Prospectus or a Prospectus pursuant to 424(b) that results in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
a new effective date under Rule 430B; (ii)&nbsp;when any supplement to the Pricing Disclosure Package, the Prospectus, or any Issuer Free Writing Prospectus or any amendment to the Prospectus has
been filed or distributed; (iii)&nbsp;of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration
Statement or any other request by the Commission for any additional information; (iv)&nbsp;of the issuance by the Commission or any other governmental or regulatory authority of any order suspending the effectiveness of the Registration Statement or
preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package, or the Prospectus or the initiation or threatening of any proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act;
(v)&nbsp;of the occurrence of any event or development within the Prospectus Delivery Period as a result of which the Prospectus, any of the Pricing Disclosure Package, or any Issuer Free Writing Prospectus as then amended or supplemented would
include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus, the Pricing Disclosure Package, or any such Issuer
Free Writing Prospectus is delivered to a purchaser, not misleading; and (vi)&nbsp;of the receipt by the Company of any notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant
to Rule 401(g)(2) under the Securities Act; and (vii)&nbsp;of the receipt by the Company of any notice with respect to any suspension of the qualification of the Shares for offer and sale in any jurisdiction or the initiation or threatening of any
proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus,
any of the Pricing Disclosure Package or the Prospectus or suspending any such qualification of the Shares and, if any such order is issued, will use its reasonable best efforts to obtain as soon as possible the withdrawal thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Ongoing Compliance.</I> (1)&nbsp;If during the Prospectus Delivery Period (i)&nbsp;any event or development shall occur
or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of
the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Prospectus to comply with law, the Company will promptly notify the Underwriters thereof and forthwith
prepare and, subject to paragraph (c)&nbsp;above, file with the Commission and furnish to the Underwriters and to such dealers as the Representatives may designate such amendments or supplements to the Prospectus (or any document to be filed with
the Commission and incorporated by reference therein) as may be necessary so that the statements in the Prospectus as so amended or supplemented (or any document to be filed with the Commission and incorporated by reference therein) will not, in the
light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will comply with law and (2)&nbsp;if at any time prior to the Closing Date (i)&nbsp;any event or development shall occur or
condition shall exist as a result of which the Pricing Disclosure Package as then amended or supplemented would include any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Pricing Disclosure
Package is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Pricing Disclosure Package to comply with law, the Company will promptly notify the Underwriters thereof and forthwith prepare and, subject
to paragraph (c)&nbsp;above, file with the Commission (to the extent required) and furnish to the Underwriters and to such dealers as the Representatives may designate such amendments or supplements to the Pricing Disclosure Package (or any document
to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Pricing Disclosure Package as so amended or supplemented will not, in the light of the circumstances existing when the Pricing
Disclosure Package is delivered to a purchaser, be misleading or so that the Pricing Disclosure Package will comply with law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Blue Sky Compliance.</I> The Company will qualify the Shares for offer and sale under the securities or Blue Sky laws of
such jurisdictions as the Representatives shall reasonably request and will continue such qualifications in effect so long as required for distribution of the Shares; <U>provided</U> that the Company shall not be required to (i)&nbsp;qualify as a
foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii)&nbsp;file any general consent to service of process in any such jurisdiction or (iii)&nbsp;subject
itself to taxation in any such jurisdiction if it is not otherwise so subject. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Earning Statement. </I>The Company
will make generally available to its security holders and the Representatives as soon as practicable an earning statement that satisfies the provisions of Section&nbsp;11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder
covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the &#147;effective date&#148; (as defined in Rule 158) of the Registration Statement; <U>provided</U> the Company will be deemed to
have furnished such statements to its security holders and the Representatives to the extent they are filed on the Commission&#146;s Electronic Data Gathering, Analysis, and Retrieval system. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Clear Market.</I> For a period of 90 days after the date of the Prospectus, the Company will not (i)&nbsp;offer, pledge,
sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with,
the Commission a registration statement under the Securities Act relating to, any shares of Stock or any securities convertible into or exercisable or exchangeable for Stock, or publicly disclose the intention to undertake any of the foregoing, or
(ii)&nbsp;enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Stock or any such other securities, whether any such transaction described in clause (i)&nbsp;or
(ii)&nbsp;above is to be settled by delivery of Stock or such other securities, in cash or otherwise, without the prior written consent of the Representatives, other than: (A)&nbsp;the Shares to be sold hereunder, (B)&nbsp;any shares of Stock of the
Company issued upon the vesting of restricted stock awards or exercise of options to purchase shares of Stock of the Company pursuant to the Company Stock Plans; or (C)&nbsp;any options to purchase Stock granted pursuant to the Company Stock Plans.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Use of Proceeds.</I> The Company will apply the net proceeds from the
sale of the Shares as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus under the heading &#147;Use of Proceeds&#148;. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>No Stabilization.</I> Neither the Company nor its subsidiaries or affiliates will take, directly or indirectly, any
action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Exchange Listing.</I> The Company will use its reasonable best efforts to list for quotation the Shares on the Nasdaq
Global Select Market. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Reports.</I> For a period of three years following the Closing Date, the Company will furnish
to the Representatives, as soon as they are available, copies of all reports or other communications (financial or other) furnished to holders of the Shares, and copies of any reports and financial statements furnished to or filed with the
Commission or any national securities exchange or automatic quotation system; <U>provided</U> the Company will be deemed to have furnished such reports and financial statements to the Representatives to the extent they are filed on the
Commission&#146;s Electronic Data Gathering, Analysis, and Retrieval system. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Record Retention</I>. The Company
will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>Shelf Renewal</I>. If immediately prior to the third anniversary (the &#147;Renewal Deadline&#148;) of the initial
effective date of the Registration Statement, any of the Shares remain unsold by the Underwriters, the Company will, prior to the Renewal Deadline, file, if it has not already done so and is eligible to do so, a new automatic shelf registration
statement relating to the Shares, in a form satisfactory to the Representatives. If the Company is not eligible to file an automatic shelf registration statement, the Company will, prior to the Renewal Deadline, if it has not already done so, file a
new shelf registration statement relating to the Shares, in a form satisfactory to the Representatives, and will use its best efforts to cause such registration statement to be declared effective within 180 days after the Renewal Deadline. The
Company will take all other action necessary or appropriate to permit the issuance and sale of the Shares to continue as contemplated in the expired registration statement relating to the Shares. References herein to the Registration Statement shall
include such new automatic shelf registration statement or such new shelf registration statement, as the case may be. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)
<I>Customer Due Diligence</I>. The Company will deliver to each Underwriter (or its agent), on the date of execution of this Agreement, a properly completed and executed Certification Regarding Beneficial Owners of Legal Entity Customers, together
with copies of identifying documentation, and the Company undertakes to provide such additional supporting documentation as each Underwriter may reasonably request in connection with the verification of the foregoing Certification. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Certain Agreements of the Underwriters</U>. Each Underwriter hereby represents and
agrees that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) It has not and will not use, authorize use of, refer to or participate in the planning for use of, any
&#147;free writing prospectus&#148;, as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and not incorporated by reference into the Registration Statement and
any press release issued by the Company) other than (i)&nbsp;a free writing prospectus that contains no &#147;issuer information&#148; (as defined in Rule 433(h)(2) under the Securities Act) that was not included (including through incorporation by
reference) in the Preliminary Prospectus or a previously filed Issuer Free Writing Prospectus, (ii)&nbsp;any Issuer Free Writing Prospectus listed on Annex A or prepared pursuant to Section&nbsp;3(c) or Section&nbsp;4(c) above (including any
electronic road show), or (iii)&nbsp;any free writing prospectus prepared by such underwriter and approved by the Company in advance in writing (each such free writing prospectus referred to in clauses (i)&nbsp;or (iii), an &#147;Underwriter Free
Writing Prospectus&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It has not and will not, without the prior written consent of the Company, use any free
writing prospectus that contains the final terms of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission; <I>provided</I> that Underwriters may use a term sheet substantially in the form
of Annex B hereto without the consent of the Company; <I>provided further</I> that any Underwriter using such term sheet shall notify the Company, and provide a copy of such term sheet to the Company, prior to, or substantially concurrently with,
the first use of such term sheet. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) It is not subject to any pending proceeding under Section&nbsp;8A of the Securities
Act with respect to the offering (and will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Conditions of Underwriters&#146; Obligations.</U> The obligation of each Underwriter to purchase the Underwritten Shares on the Closing
Date or the Option Shares on the Additional Closing Date, as the case may be, as provided herein is subject to the performance by the Company of its covenants and other obligations hereunder and to the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Registration Compliance; No Stop Order.</I> No order suspending the effectiveness of the Registration Statement shall be
in effect, and no proceeding for such purpose, pursuant to Rule 401(g)(2) or pursuant to Section&nbsp;8A under the Securities Act shall be pending before or threatened by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall
have been timely filed with the Commission under the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with Section&nbsp;4(a) hereof; and all requests by
the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Representations and Warranties.</I> The representations and
warranties of the Company contained herein shall be true and correct on the date hereof and on and as of the Closing Date or the Additional Closing Date, as the case may be; and the statements of the Company and its officers made in any certificates
delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date or the Additional Closing Date, as the case may be. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>No Material Adverse Change.</I> No event or condition of a type described in Section&nbsp;3(g) hereof shall have
occurred or shall exist, which event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the
judgment of the Representatives makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by
this Agreement, the Pricing Disclosure Package and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Officer&#146;s Certificate.</I> The
Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, a certificate of the chief financial officer or chief accounting officer of the Company and the chief executive officer
(i)&nbsp;confirming that such officers have carefully reviewed the Registration Statement, the Pricing Disclosure Package and the Prospectus and, to the knowledge of such officers, the representations set forth in Sections 3(b) and 3(d) hereof are
true and correct, (ii)&nbsp;confirming that the other representations and warranties of the Company in this Agreement are true and correct and that the Company has complied with all agreements and satisfied all conditions on its part to be performed
or satisfied hereunder at or prior to the Closing Date or the Additional Closing Date, as the case may be, and (iii)&nbsp;to the effect set forth in paragraphs (a)&nbsp;and (c). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Comfort Letters.</I> On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case
may be, PricewaterhouseCoopers LLP shall have furnished to the Representatives, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to the Underwriters, in form and substance reasonably satisfactory
to the Representatives, containing statements and information of the type customarily included in accountants&#146; &#147;comfort letters&#148; to underwriters with respect to the financial statements and certain financial information contained or
incorporated by reference in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus; provided, that the letter delivered on the Closing Date or the Additional Closing Date, as the case may be, shall use a
&#147;cut-off&#148; date no more than two business days prior to such Closing Date or such Additional Closing Date, as the case may be. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Opinion and 10b-5 Statement of Corporate and Regulatory Counsel for the Company.</I> Wilson Sonsini Goodrich&nbsp;&amp;
Rosati, Professional Corporation, corporate counsel and special counsel to the Company with respect to regulatory matters, shall have </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
furnished to the Representatives, at the request of the Company, their written opinion and 10b-5 statement, dated the Closing Date or the Additional Closing Date, as the case may be, and
addressed to the Representatives, in form and substance reasonably satisfactory to the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Opinion of
Intellectual Property Counsel for the Company</I>. Knobbe Martens, special counsel for the Company with respect to intellectual property matters, shall have furnished to the Representatives, at the request of the Company, their written opinion,
dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Representatives, in form and substance reasonably satisfactory to the Representatives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Opinion and 10b-5 Statement of Counsel for the Underwriters.</I> The Representatives shall have received on and as of
the Closing Date or the Additional Closing Date, as the case may be, an opinion and 10b-5 statement of Davis Polk&nbsp;&amp; Wardwell LLP, counsel for the Underwriters, with respect to such matters as the Representatives may reasonably request, and
such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such matters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>No Legal Impediment to Issuance and Sale.</I> No action shall have been taken and no statute, rule, regulation or order
shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares; and
no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Good Standing</I>. The Representatives shall have received on and as of the Closing Date or the Additional Closing Date,
as the case may be, satisfactory evidence of the good standing of the Company and its subsidiaries in their respective jurisdictions of organization in the State of Delaware and their good standing in such other jurisdictions as the Representatives
may reasonably request, in each case in writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Exchange Listing.</I> The Shares to be delivered on the Closing Date or the Additional Closing Date, as the case may be,
shall have been approved for listing on the Nasdaq Global Select Market, subject to official notice of issuance. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)
<I>Lock-up Agreements</I>. The &#147;lock-up&#148; agreements, each substantially in the form of Exhibit A hereto, between you and certain officers and directors of the Company relating to sales and certain other dispositions of shares of Stock or
certain other securities, delivered to you on or before the date hereof, shall be full force and effect on the Closing Date or the Additional Closing Date, as the case may be. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Additional Documents.</I> On or prior to the Closing Date or the
Additional Closing Date, as the case may be, the Company shall have furnished to the Representatives such further certificates and documents as the Representatives may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the
provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Indemnification
and Contribution</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Indemnification of the Underwriters.</I> The Company agrees to indemnify and hold harmless each Underwriter,
its affiliates, directors and officers and each person, if any, who controls such Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, from and against any and all losses, claims, damages
and liabilities (including, without limitation, legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several, that arise out of, or are
based upon, (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a material fact required to be stated therein or
necessary in order to make the statements therein, not misleading, or (ii)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any
Issuer Free Writing Prospectus, any &#147;issuer information&#148; filed or required to be filed pursuant to Rule 433(d) under the Securities Act, any road show as defined in Rule 433(h) under the Securities Act (a &#147;road show&#148;) or any
Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), or caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in light of
the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made
in reliance upon and in conformity with any information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use therein, it being understood and agreed that the only such
information furnished by any Underwriter consists of the information described as such in paragraph (b)&nbsp;below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
<I>Indemnification of the Company.</I> Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the
Company within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a)&nbsp;above, but only with respect to any losses, claims, damages or liabilities
that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to such Underwriter furnished to the Company in writing by such
Underwriter through the Representatives expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, any road show or any Pricing Disclosure
Package (including any Pricing Disclosure </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Package that has subsequently been amended), it being understood and agreed upon that the only such information furnished by any Underwriter consists of the following information in the
Prospectus furnished on behalf of each Underwriter: the concession figures appearing in the third paragraph under the caption &#147;Underwriting&#148;; the information contained in the fourteenth paragraph under the caption &#147;Underwriting&#148;
beginning with &#147;In connection with this offering, the underwriters may engage in stabilizing transactions. . .;&#148; and the first sentence of the fifteenth paragraph under the caption &#147;Underwriting&#148; beginning with &#147;The
underwriters have advised us . . . .&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Notice and Procedures.</I> If any suit, action, proceeding (including any governmental
or regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to the preceding paragraphs of this Section&nbsp;7, such person (the &#147;Indemnified
Person&#148;) shall promptly notify the person against whom such indemnification may be sought (the &#147;Indemnifying Person&#148;) in writing; <U>provided</U> that the failure to notify the Indemnifying Person shall not relieve it from any
liability that it may have under the preceding paragraphs of this Section&nbsp;7 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and <U>provided</U>,
<U>further</U>, that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under the preceding paragraphs of this Section&nbsp;7. If any such proceeding shall
be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of
the Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to this Section that the Indemnifying Person may designate in such proceeding and shall pay the
fees and expenses in such proceeding and shall pay the fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and
expenses of such counsel shall be at the expense of such Indemnified Person unless (i)&nbsp;the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii)&nbsp;the Indemnifying Person has failed within a
reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii)&nbsp;the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those
available to the Indemnifying Person; or (iv)&nbsp;the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel
would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for
the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for any Underwriter,
its affiliates, directors and officers and any control persons of such Underwriter shall be designated in writing by the Representatives and any such separate firm for the Company, its directors, its officers who signed the Registration Statement
and any control persons of the Company shall be designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent, the
Indemnifying Person agrees to indemnify each </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Indemnified Person from and against any loss or liability by reason of such settlement. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that an
Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if
(i)&nbsp;such settlement is entered into more than 30 days after receipt by the Indemnifying Person of such request and (ii)&nbsp;the Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the
date of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and
indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x)&nbsp;includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from
all liability on claims that are the subject matter of such proceeding and (y)&nbsp;does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Contribution.</I> If the indemnification provided for in paragraphs (a)&nbsp;or (b)&nbsp;above is unavailable to an Indemnified Person
or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or
payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters on the other,
from the offering of the Shares or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)&nbsp;but also the
relative fault of the Company, on the one hand, and the Underwriters on the other, in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations.
The relative benefits received by the Company, on the one hand, and the Underwriters on the other, shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company from the sale of the
Shares and the total underwriting discounts and commissions received by the Underwriters in connection therewith, in each case as set forth in the table on the cover of the Prospectus, bear to the aggregate offering price of the Shares. The relative
fault of the Company, on the one hand, and the Underwriters on the other, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a
material fact relates to information supplied by the Company or by the Underwriters and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Limitation on Liability.</I> The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to
paragraph (d)&nbsp;above were determined by <U>pro rata</U> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred to
in paragraph (d)&nbsp;above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d)&nbsp;above shall be deemed to include, subject to the limitations set forth
above, any legal or other expenses incurred by such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of paragraphs (d)&nbsp;and (e), in no event shall an Underwriter be required to contribute any
amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Shares exceeds the amount of any damages that such Underwriter has otherwise been required to
pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any
person who was not guilty of such fraudulent misrepresentation. The Underwriters&#146; obligations to contribute pursuant to paragraphs (d)&nbsp;and (e)&nbsp;are several in proportion to their respective purchase obligations hereunder and not joint.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Non-Exclusive Remedies.</I> The remedies provided for in this Section&nbsp;7 are not exclusive and shall not limit any rights or
remedies which may otherwise be available to any Indemnified Person at law or in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Effectiveness of Agreement</U>. This
Agreement shall become effective as of the date first written above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Termination</U>. This Agreement may be terminated in the
absolute discretion of the Representatives, by notice to the Company, if after the execution and delivery of this Agreement and on or prior to the Closing Date or, in the case of the Option Shares, prior to the Additional Closing Date
(i)&nbsp;trading generally shall have been suspended or materially limited on or by any of the New York Stock Exchange or The Nasdaq Stock Market; (ii)&nbsp;trading of any securities issued or guaranteed by the Company shall have been suspended on
any exchange or in any over-the-counter market; (iii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or (iv)&nbsp;there shall have occurred any outbreak or escalation of
hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representatives, is material and adverse and makes it impracticable or inadvisable to proceed with the
offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Defaulting Underwriter</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If, on the Closing Date or the Additional Closing Date, as the case may be, any Underwriter defaults on its obligation to purchase the
Shares that it has agreed to purchase hereunder on such date, the non-defaulting Underwriters may in their discretion arrange for the purchase of such Shares by other persons satisfactory to the Company on the terms contained in this Agreement. If,
within 36 hours after any such default by any Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such Shares, then the Company shall be entitled to a further period of 36 hours within which to procure other persons
satisfactory to the non-defaulting Underwriters to purchase such Shares on such terms. If other persons become obligated or agree to purchase the Shares of a defaulting Underwriter, either the <FONT STYLE="white-space:nowrap">non-defaulting</FONT>
Underwriters or the Company may postpone the Closing Date or the Additional Closing Date, as the case may be, for up to five full business days in order to effect any changes that in the opinion of counsel for the Company or counsel for the
Underwriters may be necessary in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to the Registration Statement and the
Prospectus that effects any such changes. As used in this Agreement, the term &#147;Underwriter&#148; includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to
this Section&nbsp;10, purchases Shares that a defaulting Underwriter agreed but failed to purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If, after giving effect to any
arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate number of Shares that remain unpurchased on the Closing
Date or the Additional Closing Date, as the case may be, does not exceed one-eleventh of the aggregate number of Shares to be purchased on such date, then the Company shall have the right to require each non-defaulting Underwriter to purchase the
number of Shares that such Underwriter agreed to purchase hereunder on such date plus such Underwriter&#146;s pro rata share (based on the number of Shares that such Underwriter agreed to purchase on such date) of the Shares of such defaulting
Underwriter or Underwriters for which such arrangements have not been made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If, after giving effect to any arrangements for the
purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate number of Shares that remain unpurchased on the Closing Date or the
Additional Closing Date, as the case may be, exceeds one-eleventh of the aggregate amount of Shares to be purchased on such date, or if the Company shall not exercise the right described in paragraph (b)&nbsp;above, then this Agreement or, with
respect to any Additional Closing Date, the obligation of the Underwriters to purchase Shares on the Additional Closing Date, as the case may be, shall terminate without liability on the part of the non-defaulting Underwriters. Any termination of
this Agreement pursuant to this Section&nbsp;10 shall be without liability on the part of the Company, except that the Company will continue to be liable for the payment of expenses as set forth in Section&nbsp;11 hereof and except that the
provisions of Section&nbsp;7 hereof shall not terminate and shall remain in effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Nothing contained herein shall relieve a
defaulting Underwriter of any liability it may have to the Company or any non-defaulting Underwriter for damages caused by its default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Payment of Expenses</U><I>. </I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay or
cause to be paid all costs and expenses incident to the performance of its obligations hereunder, including without limitation, (i)&nbsp;the costs incident to the authorization, issuance, sale, preparation and delivery of the Shares and any taxes
payable in that connection; (ii)&nbsp;the costs incident to the preparation, printing and filing under the Securities Act of the Registration Statement, the Preliminary Prospectus, any Issuer Free Writing Prospectus, any Pricing Disclosure Package
and the Prospectus (including all exhibits, amendments and supplements thereto) and the distribution thereof; (iii)&nbsp;the fees and expenses of the Company&#146;s counsel and independent accountants; (iv)&nbsp;the fees and expenses incurred in
connection with the registration or qualification and determination of eligibility for investment of the Shares under the state or foreign securities or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
blue sky laws of such jurisdictions as the Representatives may designate and the preparation, printing and distribution of a Blue Sky Memorandum (provided, however, that such fees and expenses
shall not exceed $10,000 without the prior written consent of the Company); (v)&nbsp;the cost of preparing stock certificates; (vi)&nbsp;the costs and charges of any transfer agent and any registrar; (vii)&nbsp;all expenses and application fees
incurred in connection with any filing with, and clearance of the offering by, FINRA (including the fees and expenses of counsel to the Underwriters up to $35,000); (viii)&nbsp;travel (including 50% of chartered aircraft expenses), meal and lodging
costs for Company employees incurred in connection with any &#147;road show&#148; presentation to potential investors; and (ix)&nbsp;all expenses and application fees related to the listing of the Shares on the Nasdaq Global Market. It is understood
and agreed that except as provided in Section&nbsp;7 and this Section&nbsp;11, the Underwriters shall pay all of their costs and expenses incurred in connection with this Agreement and the offering contemplated hereby, including fees and
disbursements of their counsel, stock transfer taxes payable on their resale of any of the Shares, travel (including 50% of chartered aircraft expenses), meal and lodging costs and other expenses of the Representatives incurred in connection with
any &#147;road show&#148; presentation to potential investors, and any advertising expenses in connection with any offers made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If
(i)&nbsp;this Agreement is terminated pursuant to Section&nbsp;9, (ii)&nbsp;the Company for any reason fails to tender the Shares for delivery to the Underwriters or (iii)&nbsp;the Underwriters decline to purchase the Shares for any reason permitted
under this Agreement, the Company agrees to reimburse the Underwriters for all out-of-pocket costs and expenses (including the fees and expenses of their counsel) reasonably incurred by the Underwriters in connection with this Agreement and the
offering contemplated hereby; <U>provided</U>, <U>however</U>, that for purposes of this Section&nbsp;11(b), the Company shall in no event be liable to any of the Underwriters for any other amounts (for the avoidance of doubt, not including any
amounts under Section&nbsp;7 hereof), including, without limitation, damages on account of loss of anticipated profits from the sale of the Shares. Notwithstanding anything herein to the contrary, in the event of termination pursuant to
Sections&nbsp;9(i), (iii)&nbsp;or (iv), the Company shall not be responsible, or obligated to reimburse the Underwriters, for any costs or expenses incurred by the Underwriters in connection with any road show. For the avoidance of doubt, it is
understood that the Company shall not pay or reimburse any costs, fees or expenses incurred by any Underwriter that defaults on its obligations to purchase the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Persons Entitled to Benefit of Agreement</U>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and
their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each Underwriter referred to in Section&nbsp;7 hereof. Nothing in this Agreement is intended or shall be construed to
give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Shares from any Underwriter shall be deemed to be a successor merely by reason of such
purchase. In all dealings hereunder, the Representatives shall act on behalf of each of the Underwriters, and the parties hereto shall be entitled to act and rely upon any statement, request, notice or agreement on behalf of any Underwriter made or
given by any Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Survival</U>. The respective indemnities, rights of contribution, representations, warranties and
agreements of the Company and the Underwriters contained in this Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Agreement or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
certificate delivered pursuant hereto shall survive the delivery of and payment for the Shares and shall remain in full force and effect, regardless of any termination of this Agreement or any
investigation made by or on behalf of the Company or the Underwriters or the directors, officers, controlling persons or affiliates referred to in Section&nbsp;7 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Certain Defined Terms</U>. For purposes of this Agreement, (a)&nbsp;except where otherwise expressly provided, the term
&#147;affiliate&#148; has the meaning set forth in Rule 405 under the Securities Act; (b)&nbsp;the term &#147;business day&#148; means any day other than a day on which banks are permitted or required to be closed in New York City; (c)&nbsp;the term
&#147;subsidiary&#148; has the meaning set forth in Rule 405 under the Securities Act; and (d)&nbsp;the term &#147;significant subsidiary&#148; has the meaning set forth in Rule 1-02 of Regulation S-X under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Compliance with USA Patriot Act</U>. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed
into law October&nbsp;26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company, which information may include the name and address of their respective clients,
as well as other information that will allow the Underwriters to properly identify their respective clients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Miscellaneous</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Notices.</I> All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if
mailed or transmitted and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Representatives c/o J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179 (fax: (212)&nbsp;622-8358);
Attention Equity Syndicate Desk and c/o Morgan Stanley&nbsp;&amp; Co. LLC, 1585 Broadway, New York, New York 10036, Attention: Equity Syndicate Desk, with a copy to the Legal Department, and to Davis Polk and Wardwell LLP, 1600 El Camino Real, Menlo
Park, California 94025 (fax: (650)&nbsp;752-2111), Attention: Alan Denenberg. Notices to the Company shall be given to it at iRhythm Technologies, Inc., 650 Townsend Street, Suite 380, San Francisco, California 94103 (fax: (415)&nbsp;632-5701);
Attention: Chief Executive Officer, with a copy to Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C., 650 Page Mill Road, Palo Alto, California 94304, (fax: (650)&nbsp;493-6811), Attention: Philip Oettinger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Governing Law.</I> This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by
and construed in accordance with the laws of the State of New York applicable to agreements made and to be performed in such state. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)
<I>Submission to Jurisdiction</I>. The Company hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to
this Agreement or the transactions contemplated hereby. The Company waives any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. The Company agrees that final judgment in any such
suit, action or proceeding brought in such court shall be conclusive and binding upon the Company and may be enforced in any court to the jurisdiction of which Company is subject by a suit upon such judgment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Waiver of Jury Trial.</I> Each of the parties hereto hereby waives any right to trial
by jury in any suit or proceeding arising out of or relating to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Recognition of the U.S. Special Resolution
Regimes</I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S.
Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution
Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a
proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S.
Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">As used in
this Section&nbsp;16(g): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;BHC Act Affiliate&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be
interpreted in accordance with, 12 U.S.C. &#167; 1841(k). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;Covered Entity&#148; means any of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(i) a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(iii) a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;Default Right&#148; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81,
47.2 or 382.1, as applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;U.S. Special Resolution Regime&#148; means each of (i)&nbsp;the Federal Deposit Insurance Act and the
regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Counterparts.</I> This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of
telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Amendments or Waivers.</I> No amendment or waiver of any provision of this Agreement,
nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Headings.</I> The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the
meaning or interpretation of, this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding, please indicate your acceptance
of this Agreement by signing in the space provided below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="35%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">iRhythm Technologies, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;/s/ Kevin M. King</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;Name: Kevin M. King</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;Title: Chief Executive Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Underwriting Agreement</I>] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="32%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted: As of the date first written above</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SECURITIES LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MORGAN STANLEY&nbsp;&amp; CO. LLC</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For themselves and on behalf of the</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">several Underwriters listed</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">in Schedule 1 hereto.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="49" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. MORGAN SECURITIES LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;/s/ Benjamin Burdett</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">Name:&#8201;&#8202;Benjamin Burdett</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">Title:&#8194;&#8201;&#8202;Managing Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="49" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MORGAN STANLEY&nbsp;&amp; CO. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;/s/ Matthew Strom</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">Name:&#8201;&#8202;Matthew Strom</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">Title:&#8194;&#8201;&#8202;Executive Director</P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Underwriting Agreement</I>] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Schedule 1 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Underwriter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of&nbsp;Shares</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">547,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">547,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Canaccord Genuity LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">171,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BTIG, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,369,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Annex A </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Pricing Disclosure Package</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;Free Writing Prospectuses: None </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Pricing Information Provided Orally by Underwriters</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">Price to Public: $73.00 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">Number
of Shares: 1,369,863 (plus 205,479 Option Shares) </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">Underwriting discounts and commissions: $4.38 </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">ANNEX B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">IRHYTHM TECHNOLOGIES, INC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Pricing Term Sheet </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">None.
</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF LOCK-UP AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;</U>, 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SECURITIES LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MORGAN
STANLEY&nbsp;&amp; CO. LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As Representatives of </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the
several Underwriters listed in </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule 1 to the Underwriting </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Agreement referred to below </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o J.P. Morgan Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">383 Madison Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10179 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Morgan Stanley&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1585 Broadway </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10036 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Re: iRhythm Technologies, Inc. &#151;
Public Offering </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
undersigned understands that J.P. Morgan Securities LLC and Morgan Stanley&nbsp;&amp; Co. LLC, as representatives of the several Underwriters (the &#147;Representatives&#148;), propose to enter into an underwriting agreement (the &#147;Underwriting
Agreement&#148;) with iRhythm Technologies, Inc., a Delaware corporation (the &#147;Company&#148;), providing for the public offering (the &#147;Public Offering&#148;) by the several Underwriters named in Schedule 1 to the Underwriting Agreement
(the &#147;Underwriters&#148;), of common stock, $0.001 per share par value, of the Company (the &#147;Securities&#148;). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In consideration of the Underwriters&#146; agreement to purchase and make the Public Offering of the Securities, and for other good and
valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of the Representatives on behalf of the Underwriters, the undersigned will not, during the period beginning on the
date of this letter agreement (this &#147;Letter Agreement&#148;) and ending 90 days after the date of the Underwriting Agreement (such period, the &#147;Restricted Period&#148;), (1)&nbsp;offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of common stock, $0.001 per share par value, of the Company
(the &#147;Common Stock&#148;) or any securities convertible into or exercisable or exchangeable for </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Common Stock (including without limitation, Common Stock or such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of
the Securities and Exchange Commission and securities which may be issued upon exercise of a stock option or warrant), or publicly disclose the intention to undertake any of the foregoing, (2)&nbsp;enter into any swap or other agreement that
transfers, in whole or in part, any of the economic consequences of ownership of the Common Stock or such other securities, whether any such transaction described in clause (1)&nbsp;or (2)&nbsp;above is to be settled by delivery of Common Stock or
such other securities, in cash or otherwise or (3)&nbsp;make any demand for or exercise any right with respect to the registration of any shares of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock. The
undersigned acknowledges and agrees that the foregoing precludes the undersigned from engaging in any hedging or other transactions designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition of any
shares of Common Stock, or securities convertible into or exercisable or exchangeable for Common Stock. Notwithstanding the foregoing, the terms of this Letter Agreement shall not apply to or prohibit: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transactions relating to shares of Common Stock acquired in open market transactions after the completion of
the Public Offering; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers to the spouse, domestic partner, parent, sibling, child or grandchild of the undersigned or any other
person with whom the undersigned has a relationship by blood, marriage or adoption not more remote than first cousin (each, an &#147;immediate family member&#148;) or to a trust, or other entity formed for estate planning purposes, formed for the
direct or indirect benefit of the undersigned or of an immediate family member of the undersigned; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers as a bona fide gift or gifts or by will or intestacy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the undersigned is a corporation, partnership, limited liability company or other business entity, transfers
(x)&nbsp;to another corporation, partnership, limited liability company or other business entity that controls, is controlled by or is under common control with the undersigned, or (y)&nbsp;as part of a disposition, transfer or distribution by the
undersigned to its members, limited partners or equity holders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the undersigned is a trust, transfers to a trustor or beneficiary of the trust; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the receipt by the undersigned from the Company of shares of Common Stock (the &#147;Plan Shares&#148;) upon
the vesting of restricted stock awards or exercise of options to purchase the Company&#146;s securities issued pursuant to the Company&#146;s equity incentive plans or the transfer of shares of Common Stock or any securities convertible into Common
Stock to the Company upon a vesting event of the Company&#146;s securities or upon the exercise of options or warrants to purchase the Company&#146;s securities, in each case on a &#147;cashless&#148; or &#147;net exercise&#148; basis in connection
with such vesting or exercise, provided that the Plan Shares shall be subject to the terms of this Letter Agreement, and provided further that any filing under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), shall
clearly indicate in the footnotes thereto that (i)&nbsp;the filing relates to the circumstances described in this clause (f) and (ii)&nbsp;no Securities or other securities were sold by the reporting person and that no other public announcement or
filing is required of or voluntarily made by or on behalf of the undersigned or the Company regarding such transfer; </P></TD></TR></TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the transfer of shares of Common Stock or any security convertible into or exercisable or exchangeable for
Common Stock to the Company, pursuant to agreements existing as of the date hereof under which the Company has the option to repurchase such shares or securities or a right of first refusal with respect to transfers of such shares or securities,
provided that any filing under the Exchange Act shall clearly indicate in the footnotes thereto that (i)&nbsp;the filing relates to the circumstances described in this clause (g) and (ii)&nbsp;no Securities or other securities were sold by the
reporting person and that no other public announcement or filing is required of or voluntarily made by or on behalf of the undersigned or the Company regarding such transfer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the establishment of a trading plan pursuant to Rule 10b5-1 under the Exchange Act (a &#147;10b5-1 Plan&#148;)
for the transfer of shares of Common Stock, provided that (i)&nbsp;such plan does not provide for the transfer of Common Stock during the Restricted Period, unless the details of such 10b5-1 Plan were communicated to the Representatives prior to the
execution of this Letter Agreement, and (ii)&nbsp;no public announcement or filing under the Exchange Act is required of or voluntarily made by or on behalf of the undersigned or the Company regarding the establishment of such plan;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the transfer of shares of Common Stock or any security convertible into or exercisable or exchangeable for
Common Stock that occurs by operation of law including pursuant to a qualified domestic order or in connection with a divorce settlement, provided that any filing under the Exchange Act shall clearly indicate in the footnotes thereto that
(i)&nbsp;the filing relates to the circumstances described in this clause (i) and (ii)&nbsp;no Securities or other securities were sold by the reporting person and that no other public announcement or filing is required of or voluntarily made by or
on behalf of the undersigned or the Company regarding such transfer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the transfer of shares of Common Stock or of any security convertible into or exercisable or exchangeable for
Common Stock in connection with a bona fide third-party tender offer, merger, consolidation or other similar transaction made to all holders of the Company&#146;s capital stock involving a change of control (as defined below) of the Company that has
been approved by the Company&#146;s board of directors and that occurs after the date of the final prospectus supplement used to sell the Securities; provided, however, that in the event that such tender offer, merger, consolidation or other such
transaction is not completed, the shares of Common Stock and other securities convertible, exercisable or exchangeable for shares of Common Stock held by the undersigned shall remain subject to the provisions of this Letter Agreement. For purposes
of this clause (j), &#147;change of control&#148; means the consummation of any bona fide third party tender offer, merger, consolidation or other similar transaction the result of which is that any &#147;person&#148; (as defined in
Section&nbsp;13(d)(3) of the Exchange Act), or group of persons, other than the Company, becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of 50% of the total voting power of the voting stock of the Company; or
</P></TD></TR></TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the transfer of shares of Common Stock pursuant to a 10b5-1 Plan; provided that the details of such 10b5-1 Plan
were communicated to the Representatives prior to the execution of this Letter Agreement and such 10b5-1 Plan will not be amended or otherwise modified during the Restricted Period; provided that any filing required under the Exchange Act shall
clearly indicate in the footnotes thereto that (i)&nbsp;the filing relates to the circumstances described in this clause (k) and (ii)&nbsp;no Securities or other securities were sold by the reporting person and that no other public announcement or
filing is required of or voluntarily made by or on behalf of the undersigned or the Company regarding such transfer; </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, however:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(x) in the case of any transfer or distribution pursuant to clauses (b) &#150; (e) and (i), each transferee, donee or distributee shall
execute and deliver to the Representatives a lock-up letter in the form of this Letter Agreement; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(y) in the case of any transfer or
distribution pursuant to clauses (a) &#150; (e), no filing by any party (donor, donee, transferor or transferee) under the Exchange Act or other public announcement shall be required or shall be made voluntarily during the Restricted Period in
connection with such transfer or distribution (other than a filing on a Form 5 made after the expiration of the Restricted Period); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
undersigned hereby waives any rights the undersigned may have to require registration of Common Stock in connection with the filing of a registration statement relating to the Public Offering. The undersigned further agrees that, for the Restricted
Period, the undersigned will not, without the prior written consent of the Representatives on behalf of the Underwriters, make any demand for, or exercise any right with respect to, the registration of Common Stock or any other securities of the
Company that are substantially similar to Common Stock (including any securities that derive value therefrom), or any securities convertible into or exercisable or exchangeable for Common Stock, or warrants or other rights to purchase Common Stock
or any such other securities. In addition, the undersigned hereby waives any and all preemptive rights, participation rights, resale rights, rights of first refusal and similar rights that the undersigned may have in connection with the Public
Offering or with any issuance or sale by the Company of any equity or other securities before the Public Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In furtherance of the
foregoing, the Company, and any duly appointed transfer agent for the registration or transfer of the securities described herein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or
breach of this Letter Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby represents and warrants that the undersigned has full power and authority to
enter into this Letter Agreement. All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned understands that, if the Underwriting Agreement does not become effective by November&nbsp;30, 2019, or if the Underwriting
Agreement (other than the provisions </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common Stock to be sold thereunder, the undersigned shall be released from all
obligations under this Letter Agreement. The undersigned understands that the Underwriters are entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this Letter Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Letter Agreement and any claim, controversy or dispute arising under or related to this Letter Agreement shall be governed by and
construed in accordance with the laws of the State of New York, without regard to the conflict of laws principles thereof. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Signature Page Follows</I>]<I> </I></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>IF AN INDIVIDUAL:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>IF AN ENTITY:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:10pt"><I>(duly authorized signature)</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt"><I>(please print complete name of entity)</I></FONT></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><I>(please print full name)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;&nbsp;(duly authorized signature)</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;&nbsp;&nbsp;&nbsp;(please print full name)</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;&nbsp;&nbsp;&nbsp;(please print full title)</I></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Address:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">E-mail:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">E-mail:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Lock-Up Agreement</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d765496dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle"> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g765496g41j52.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">650 Page Mill Road</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">Palo Alto, CA 94304-1050</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right"><SMALL>PHONE</SMALL> 650.493.9300</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right"><SMALL>FAX</SMALL> 650.493.6811</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="right"><B>www.wsgr.com</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">September 10, 2019 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">iRhythm Technologies, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">650 Townsend Street, Suite 500 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94103 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as counsel to iRhythm Technologies, Inc., a Delaware corporation (the &#147;<U>Compan</U>y&#148;), in connection with the filing by the Company
with the Securities and Exchange Commission (the &#147;<U>Commission</U>&#148;) on September&nbsp;4, 2019 of a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File
<FONT STYLE="white-space:nowrap">No.&nbsp;333-233619)</FONT> (the &#147;<U>Registration Statement</U>&#148;), under the Securities Act of 1933, as amended (the &#147;<U>Act</U>&#148;); the prospectus contained within the Registration Statement (the
&#147;<U>Prospectus</U>&#148;); and the prospectus supplement to the Registration Statement dated September&nbsp;5, 2019 (the &#147;<U>Prospectus Supplement</U>&#148;) filed with the Commission. The Prospectus Supplement relates to the offering by
the Company of up to 1,575,342 shares of the Company&#146;s common stock (the &#147;<U>Common Stock</U>&#148;), $0.001 par value per share (the &#147;<U>Shares</U>&#148;), covered by the Registration Statement. The Shares include an option granted
to the underwriters of the offering to purchase 205,479 shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The offering and sale of the Shares are being made pursuant to the
Underwriting Agreement (the &#147;<U>Underwriting Agreement</U>&#148;), dated as of September&nbsp;5, 2019, by and among the Company and J.P. Morgan Securities LLC and Morgan Stanley&nbsp;&amp; Co. LLC, as representatives of the several underwriters
named therein (the &#147;<U>Underwriters</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have examined copies of the Underwriting Agreement, the Registration Statement, the Prospectus
that forms a part thereof and the Prospectus Supplement thereto related to the offering of the Shares. We have also examined instruments, documents and records which we deemed relevant and necessary for the basis of our opinion hereinafter
expressed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In such examination, we have assumed (i)&nbsp;the authenticity of original documents and the genuineness of all signatures, (ii)&nbsp;the
conformity to the originals of all documents submitted to us as copies, and (iii)&nbsp;the truth, accuracy, and completeness of the information, representations and warranties contained in the records, documents, instruments and certificates we have
reviewed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on and subject to the foregoing, we are of the opinion that the Shares have been duly authorized by the Company and, when issued and
delivered by the Company against payment therefor in accordance with the terms of the Underwriting Agreement, will be validly issued, fully paid and nonassessable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>AUSTIN&nbsp;&nbsp;&nbsp;&nbsp;BEIJING&nbsp;&nbsp;&nbsp;&nbsp;BOSTON&nbsp;&nbsp;&nbsp;&nbsp;BRUSSELS&nbsp;&nbsp;&nbsp;&nbsp;HONG&nbsp;KONG&nbsp;
&nbsp;&nbsp;&nbsp;LONDON&nbsp;&nbsp;&nbsp;&nbsp;LOS&nbsp;ANGELES&nbsp;&nbsp;&nbsp;&nbsp;NEW&nbsp;YORK&nbsp;&nbsp;&nbsp;&nbsp;PALO&nbsp;ALTO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>SAN&nbsp;DIEGO&nbsp;&nbsp;&nbsp;&nbsp;SAN&nbsp;FRANCISCO&nbsp;&nbsp;&nbsp;&nbsp;SEATTLE&nbsp;&nbsp;&nbsp;&nbsp;SHANGHAI&nbsp;&nbsp;&nbsp;&nbsp;
WASHINGTON,&nbsp;DC&nbsp;&nbsp;&nbsp;&nbsp;WILMINGTON,&nbsp;DE </B></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g765496g13b13.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;10, 2019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page
2 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We express no opinion herein as to the laws of any state or jurisdiction, other than the Federal laws of the
United States of America and the General Corporation Law of the State of Delaware (the &#147;<U>DGCL</U>&#148;), as such are in effect on the date hereof, and we have made no inquiry into, and we express no opinion as to, the statutes, regulations,
treaties, common laws or other laws of any other nation, state or jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We express no opinion as to (i)&nbsp;the effect of any bankruptcy,
insolvency, reorganization, arrangement, fraudulent conveyance, moratorium or other similar laws relating to or affecting the rights of creditors generally, (ii)&nbsp;rights to indemnification and contribution which may be limited by applicable law
or equitable principles, or (iii)&nbsp;the effect of general principles of equity, including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing, the effect of judicial discretion and the possible unavailability
of specific performance, injunctive relief or other equitable relief, and the limitations on rights of acceleration, whether considered in a proceeding in equity or at law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion as an exhibit to the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed
on or about September&nbsp;10, 2019, for incorporation by reference into the Registration Statement, and to the use of our name wherever it appears in the Registration Statement, the Prospectus, Prospectus Supplement, and in any amendment or
supplement thereto. In giving such consent, we do not believe that we are &#147;experts&#148; within the meaning of such term as used in the Act or the rules and regulations of the Commission issued thereunder with respect to any part of the
Registration Statement, including this opinion as an exhibit or otherwise. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>/S/ WILSON SONSINI GOODRICH&nbsp;&amp; ROSATI, P.C.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WILSON SONSINI GOODRICH&nbsp;&amp; ROSATI</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Professional Corporation</P></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>irtc-20190905.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.8.2 - Release 2019.2 -->
<!-- Creation date: 9/10/2019 6:24:55 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:irtc="http://www.irhythmtech.com/20190905"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.irhythmtech.com/20190905"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="irtc-20190905_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="irtc-20190905_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>irtc-20190905_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.8.2 - Release 2019.2 -->
<!-- Creation date: 9/10/2019 6:24:55 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>irtc-20190905_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.8.2 - Release 2019.2 -->
<!-- Creation date: 9/10/2019 6:24:55 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="irtc-20190905.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g765496g13b13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g765496g13b13.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M">@ H AANH+AYDAF1V@?RY ISL; .#Z'!!_&@!;BZ@M(Q)<2I$A=4#,< LQ
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M1E61B)"%!.%  //S+GF@#K;76)?^$QLM+74HKJTET^2<-A=[N)% .5XQ@G@
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MDL=K8&&4%CC/2@#5H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
@* "@ H * "@ H * "@ H * "@ H * "@ H * "@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g765496g41j52.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g765496g41j52.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MYH Z+X5^(M5\1>%KA]8=9KNRO)+0W"KM$P3'S8''?''I0!W% '">)+R+PO\
M$+2M<F.RTU"SEL;@]MZ#S8_Q.) /K0!AV;WGA_6=<T2XE*W?B&WBO8,G[L\K
M>5,!_NDJ?H* .ON[R]T[QIX>T:VDBCTN:UG+1"/YLQA0HW9Z?-T [4 8-GJ.
MIV.@^++S2K:2YN(]=D#)"H>01YC#E%/#,%R0/6@"W:^*9+VQT"UT_6!=-J]W
M+&+UH0CQHBLY4I@ 2#:%Y&.^* ([[7M>TI?%NF->QS7.FV U"RNY(1DH0_R.
MHP"08R 1V(R/4 FT[4]?MO$?AR'4-3BN[?6+21WA6W$8A=$1@5(Y.<D'/Z4
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M&-%:XB\]5!(Q@'![#!QZ$T =7<WFK:;XM\-:2=1^TVETERT[R1*)9"B@KRH
M ^8= .G6@#K* ,CQ1H-OXG\,ZAHUS@)=1% W]QNJM^! /X4 >8-<GQ;\$;^V
MU2;[-KGAPE))&/S1W$'W&^K#C/J30!J>'->8_"8ZM93"77M9G:-F(P?MDC;,
M8[! !_P%* *.O^.-.\'^!=3\-6L,*ZIIK+I\%M< ,)48#;,0?O @DGKSUZT
M'PB\)6NDZUXC-LL=]I(\B*"[DC4B64)^^*''W=QQQQ^5 'H-CX2T[2_%4^N:
M?#':M<VWDW$,4859&# J_'?J.G.1Z4 >3^&M'\0W_@CQC-X<UJZM+U-8NMEM
M&$V2XVDC.W<&(X!!'04 >D?#/6-'UCP/8OH]K'91P#RIK1/^6,H^\#GGD\Y/
M)S0!U] &1XA\.V?B.VLX+S[MK=Q7:<9^9&SCZ$9'XT &H>';34?$6D:U-_Q\
M:6)1$,=?,4*?RQ0 V^\/B]\1Z?K7VZ:*6QCDCCB55*$/C=G(S_"._% &;9^"
MFL+>[CM]=OUDN+TW_F@1[DE/WL?+@J1QM(H FD\$:=)IR0":>.Z2\-^EXA E
M6X)Y?IMYR05QC'&* %G\'P76GZO!/?W+W6K1B&YN\('\L @(HQM48+=NK$]:
M 'KX54:EHMZVI7+/I$311*53#A@ Q;Y>N !QCI0!>UO1_P"V;:&-;ZYL98)A
M-'/;%0ZL 1_$""""001S0!5@\-*]\E[JU[)J=Q'"\$?FHBHB/C?A5 &2  2>
MW3'- %:P\%6MDFGVS7UW<:=ILGFVEI*5*QL,[<MC<P7/R@GCCK@4 ,E\$PRV
M7B&U?5+LIKK%K@XCRN5"$+\O'R@#G/YT /N_!L=]&;>ZU2\DLI88XKBV.S9-
ML/!^[E2> =I&<"@"9O"^=9U74TU.YCEU&!;=U54VHJAMNW*]1N;KZT 5H?!4
M4%EX?M$U2[\O0V#6^0F6PI0;OEY^5B.,=: -#1O#ZZ-?ZI=)>S3'49_M$B.J
MA5?:%^7 !Z*!S0!)KWAZP\1V<=O>JZM#()8)X7V2PR#HR-V- &7>^#I]52TB
MU3Q#?W-O:SI.B*D49=T.5+$+DX(SQB@"2Y\&6TL^IFWO[NTMM5.Z]MX2NV5L
M;6()!*%@,$@C/UYH EE\)6T>I#4-+NY]+N#;K:R?9PI5XU^X"K C*\X(]<<T
M 5I? FFJFE'3[J[TVXTQ&CAGMG&]D8Y=7W ALGDY'7F@"F?AXK:/JVEG7+W[
M/J-Z+QSM0NK94XR0<Y*K0!L:IX<;5FTEYM4N$ETVX^THZ(@+OM*C=QTPQ&!B
M@""U\(KIVM7=]IVK7MI;7LWVBXLTV&-Y.[ E25SCG!YH @?P/%+X=U#1I-5N
MVAO[HW4DFU-P8OO8#Y<8)^N* .G\H/;^3,?-!7:^X?>XYR* .-A^&MB-)?1K
MK5M2N](4$6UG)(H6W_NX8*&.W^'<3C ]!0!T^DZ8=+M6CDO9[V=SNDGG(W.0
M !PH ' '0>_4T 48?#?D^,+CQ$-1G:2>!;=K<JOEA%)*XXSG))SGO0!FZC\/
M[*]O+UH;J2VL]0D6>YMD' G4@K-&V<QR9 R>0<<B@"ZWA-)C=3W>IWD]_/;_
M &9;O*(\*9W?(%4 '< 2<'.!V&* *MSX$@N@T\FIW1U)KJ"Z>\VQ[F:($("N
MW;@ GMU.: &'X?VITJ^L/[5OB+F^&H)*2A>&8.'W+\O/S#H<CZ4 :$OAEIM9
MTG4Y=6NWFTT2!0P3$F_&[=\OH !C&* -^@ H \UU#P+?2?%5=0MF*:!J"1W.
MHQC&))X3F,$>Y*GWVG- #]!\#WNE_$S4[MB1X>$AU"TBXVBZE78YQ[ -_P!]
MB@"S\7O"=QXJ\$3)I\"RZC:2+<0KM&Y]N<J#[@GCN0* -OPAXEL/%GAJ"YLI
M1#,(Q'<0+@/;2 892O;!Z9% ')Z9/K=W\4];\,S>*K\V-G9QSQ!4@$FYMN<G
MR^@SZ=Q0!U7A?P58^$9+DZ=>W[QW+M++%/*'5I#C+],YX]: "V\$:9I_BB?7
M],FN;"XNCFZA@<>3<'U9"#S[C!Y/K0!TM %'4=5@TQ[5)DF=KJ0Q1")-V6VE
ML?DI_*@"I+XHTR.&TFC>6>.[C>6(PQ,V53[V1U!&>G7M0!9DUFS6&VDB9[C[
M5'YL*PJ69TP#N ].1R?4>M $!\2Z=_9L%\CR20S3BW 6,[ED+;=K+U4[N.>]
M $LNMVT(M/,BN%>ZE:&)#"=Q90Q/';A2<].* %DUFWBBMV:*?S;@,8X/*/F'
M;][Y?;^HH )M:M89$CVSR2&-962.(L41C@%AVY!_(^E #DU>T:_O+,LR26<:
MRS,Z[456S@[NG\)_*@".WUZRN+V&T_>Q2W"%X/-B9!,!UVD]3CG'7'.* (H_
M$VF2V-_=0R22#3Y&CN8EC/F1LIY!7K[^XZ4 7KC4;2TN+.WN)1'->.8X4;JS
M!2Q'Y T )_:-N-6&F?/]I\GS_N';MSCKTSGM0!9DD2&)Y975(T!9F8X  ZDT
M 4;/6+>^*>5'.L<D9ECE>)E1EXYR>G4=<4 11>(M/ENK6 -*@N\_9I'B*QS8
M&<*W3. 2/4#(S0 D'B+3[C438JTJR^<]NI:,A6D5=S*#Z[>?< T $GB*PAU*
M6QE,L;Q21QL[1G8&D^X-W3GI]>* %O?$-A8&<S&4Q6Q N)4B9DAXS\Q'3@@G
MT!R<4 )J'B/3]+F,=RTN%@^T-(D19%CS@L2.PS^7- %S4-1M-+LGO+V98K="
MH9ST&2 /U(H KZEKEMI4B+<17)#LB!XX69=SMM5<CN3C\Q0 KZU;1M8K)%<(
M][(T42M"0=P!)!].%8\]A0!'>^(M/L/.:=I/)@8+/,D9:.$_[1'3J,^F><4
M3/K-C'K,6DR3;+R:(RQ*P($BCKM/0D=<=<<T 36-['?P-+$DBJLCQD2+M.5)
M4_J#0!9H * "@ H * "@ H * "@ H * "@ H QK_ ,)Z!J=V;R[TJW>Z/!G5
M=DA^K+@F@"72_#>BZ+*\NFZ7;6TSC#RI&-[?5NI_.@#4H * "@#(US2[C4Y=
M,\AU1+:Z\Z1MY5MNQU^4@'GY_P!* ,O6/!T=_P#V=:6K"TL+:">(^7(RR*7
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$0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d765496d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="irtc-20190905.xsd" xlink:type="simple"/>
    <context id="duration_2019-09-05_to_2019-09-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001388658</identifier>
        </entity>
        <period>
            <startDate>2019-09-05</startDate>
            <endDate>2019-09-05</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2019-09-05_to_2019-09-05">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2019-09-05_to_2019-09-05"
      id="Hidden_dei_EntityCentralIndexKey">0001388658</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2019-09-05_to_2019-09-05">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2019-09-05_to_2019-09-05">2019-09-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2019-09-05_to_2019-09-05">iRhythm Technologies, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2019-09-05_to_2019-09-05">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2019-09-05_to_2019-09-05">001-37918</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2019-09-05_to_2019-09-05">20-8149544</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2019-09-05_to_2019-09-05">650 Townsend Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2019-09-05_to_2019-09-05">Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2019-09-05_to_2019-09-05">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2019-09-05_to_2019-09-05">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2019-09-05_to_2019-09-05">94103</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2019-09-05_to_2019-09-05">(415)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2019-09-05_to_2019-09-05">632-5700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2019-09-05_to_2019-09-05">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2019-09-05_to_2019-09-05">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2019-09-05_to_2019-09-05">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2019-09-05_to_2019-09-05">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2019-09-05_to_2019-09-05">Common Stock, Par Value $.0001 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2019-09-05_to_2019-09-05">IRTC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2019-09-05_to_2019-09-05">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2019-09-05_to_2019-09-05">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>97</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d765496d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d765496d8k.htm">d765496d8k.htm</File>
    <File>d765496dex11.htm</File>
    <File>d765496dex51.htm</File>
    <File>irtc-20190905.xsd</File>
    <File>irtc-20190905_lab.xml</File>
    <File>irtc-20190905_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M]8??3=AY8_?V'QM?!9L:?MU%\P502P,$%     @  H$J3YE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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MK(9F=)@8V8Z-=C)U^\4_4$L#!!0    (  *!*D^\MWU": (  $P&   4
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @  H$J3^\'1:7O    *P(  !$
M             ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M H$J3YE<G",0!@  G"<  !,              ( !MP(  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    "  "@2I/Q S=P:@"  #Y"P  &
M    @ 'X"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M H$J3[RW?4)H @  3 8  !0              ( !U@L  'AL+W-H87)E9%-T
M<FEN9W,N>&UL4$L! A0#%     @  H$J3[JA.8K7 0  ,@8   T
M     ( !< X  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  "@2I/%FTC?T,!
M   \ @  #P              @ %R$   >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @  H$J3__ )@B]    A0(  !H              ( !XA$  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @  H$J3PN/V ,A 0
M5P0  !,              ( !UQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2      H "@"  @  *10

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6627398880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 05, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001388658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  05,  2019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">iRhythm Technologies, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-8149544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">650 Townsend Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Francisco<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(415)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">632-5700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, Par Value $.0001 Per Share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IRTC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d765496d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d765496d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "irtc-20190905_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "irtc-20190905_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "irtc-20190905.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 97,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "irtc",
   "nsuri": "http://www.irhythmtech.com/20190905",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d765496d8k.htm",
      "contextRef": "duration_2019-09-05_to_2019-09-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d765496d8k.htm",
      "contextRef": "duration_2019-09-05_to_2019-09-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.irhythmtech.com//20190905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-19-241995-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-19-241995-xbrl.zip
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M@!7_:'M D4D+EA34/?,<-O[*)J442 LZK F:"?I6V]_?;>S/PU>9H8Q@/2;
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MLFV#S&M%IC7@K$?:R8N\+_6+O,6\:CWX0.JH$OY=:_U7KX__!U!+ P04
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MN($3;W*<)!)(;2CA*'F]F9^/O,BN7+E3!Z<)I D7<P[?R!V$%:6)?S$^5U3
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MS$T-MU]X^X%E%MH]R,:,CAJ>II?L\.HY/(JTZ)]M\PXE'SR"#D*02.^24TL
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M'5']D%J]1PS=RBL-5+C@9/#B)9[WX*NC32V62B5#0I$B^[L2ETY]EE5_@G?
M9D983&PVU@,Z@/QB9$7#$:60=65G65&UG1.5TXD+!H54J+,SCBGA7\Y3,NB(
M"9.W!A;EHSTW60WI&L0KE?=VV3MXD7H2^N%EX2:EIW8UK\%<O6(%+^3#1Y@^
MR8I$N)IP*U60$0?*YB#(R$<$/\&+]BPGP[F&0=XT8#?ZW#VFRF=OGOK<I9+C
M_/U3X#?2#;A$TP#/KMG,N[N0CHO#ZVD%8_R6[W/HO?/IGV@6P[$X=KN&G>VN
M1#_(FI4X-Z>3,J_.X'3AM#NTO=%O1>29-VCK7$6VQV  U&I6<L0X7+Y:EQ3
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M"H6XO8 D5VA]HO"66]D.YK%S8AE)_9%)[GHS7<.,4C_8@P2J7VY2&G$3_61
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MV8)O=ET@7."R9O2$U,5F<$\(V+ZQ^Q]M<87)/UEEK_!T@O>08:X1Y<ZS8HN
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M L;&DHR-)]B7_O7;JYZUT8O$L-EVM</"-JU,;3ILXM[#L,Y+2@DZC[#B1JX
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M-/D[[*M$_5;X3\[*9IA<3.C"L;BY.:4 8FZSU!*+3U^+;F$\FFQ'\&?>GQW
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MU=$<^;Q[858? C]_\?U3:=R;/(/C> :J._:/R7LR+2A!3P:KK<4LH58DAZ[
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MQ\#'TB;J@0;5N&1O,+/\?P8A"MH-YOVZ@?,YBMHQ&%Q3"*XC;+!RG:O*D9C
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M20B7EAZ)KY7*I]!?/B>^DE5$PGEY]?40^Q)PK^55JBB2*!J)*$I(H#?R5VW
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M1?RA.7HB'TX@LL:_M5-Z:\[797C0_?9>;+T&GU0I[8*C/A-:54+-='N%EW[
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M"&V]%'=<J2W]*V"R733]12AJS_]02P,$%     @  H$J3WAMFVW(!   U2P
M !4   !I<G1C+3(P,3DP.3 U7W!R92YX;6S=FEV/XC84AN]7VO_@9F]:J2'
M?'1!PZP0,U.AS@<"MJUZLS+) :PZ-K+- /^^QP'O$@BS,-NMXLX%,([?X]?G
M<9S8R=6'9<K),RC-I&@%M4HU("!BF3 Q:05S'5(=,Q80;:A(*)<"6L$*=/#A
M^NV;JQ_"D-S<=1])2*;&S'0SBA:+1249,Z$EGQL,J2NQ3",2AJY^9_B1_+YN
MKDG:";9#+NN5R\K[2AW#]($#U4#JU5K#%GR1*: V'DFH@29I1+5J9"N1RV;]
MO'EQ07H/Y)9J TJ0(4MA6RIG*\4F4T-^C'_*(I,;*01P#BMRQP05,:.<#)SC
MGTE7Q!72YISTK4RC*PWJ&9+*)BIGXN^F_1A9K^3M&X)_F$>AL])68+.Q2<9R
MI'A%J@FZK9Y%3A1L:Y9[HL59)JDU&HTH.YJOKUE1;6R@%OWY<#^(IY#2$!D@
MLWBG*723F,_J;7,7T?J@JZ]94V>1[F6<I?Z(;I&#->Q_H:L6VJ*P5@_/:I6E
M3H)KV^0ZJTIRZ,.8V.^/_6ZN3::F*S--#<33;%1E Z#:0.>&+J60Z2JRLNA&
MQO,4A''?;9'<"L/,JBO&4J599P*2Y;4Y53!N!4R9.'31K*5W?0STZ91 9C7#
M4T.S=,8A(-%6EV8*AX\P6>U[+,@)8&E ))"X,+8#WZ_3UVNVFP$LXUP2W"F<
M@=,05R;R.4J 92W:'UF&PFIM@^T=%GWJ2)P[VB-M%(U-/A?<CANI7"&G(^"M
MH$ 4_?NVVIB"Q*;ACM/)L;9V1'E;VQ3;*LZ%I"IVX?#G'L+\F;"I$<VHPGAA
M/&7\,_VQDFEABC:MR4*C4B6@6D&]7L$9(" SQ:1"\%@2D+E&+W)F75-NC\$8
ME(+D?MWM@RXSBSB;:LAJ?A=(Z_'9P7XHRKMX%BQ_@]6QL Z(RPOM@&$'[\PS
M>&Z>&6(RCV66UY075=ZG(W3A*:$>H&.\&"0W>.MT*JH=<?F9[1AV\"X]@[>>
M+?HP8;:[PCS2]&AVQ=KRHBOVZ\C]XB4Y7$)(-9,J2_  \PP=.<>I?]61R8D@
MOQ*J[%R_8M]A?N\EYCO&X7&>CD"=QG1;5W: VUX=K8:7M(9TV4TP&6S,UDO:
MUZ [&*3L' \:WT ]JWH)M9TDF&J]^<(%-M1. UH8H.PP"TT[D+7_"<CZMX*L
M^PBR_@6DGROZ35\Z^/-)#>5"O KCMMP3B-N6'4+?UO6Y#F6W:T^JI^0SLUO)
MK^&X%\,3F'N^'=%SGXGVI#:4_\5FIZ]#BB-X0G/'M6/IVYZ.G6':"N@I]/*:
M\O+*^W2$?-NXL4_+>&\JQ8GKPGU=>4GM>W6T?-NL^0-=&A =F:9SL5D6Z6.1
M'1"7E]L!PPZ>;ULP \E9S P3DP>\5"MF#1Y'KDA97FQ%;ATSWS9B>@KL\ .\
MH\J>L-B'W^II/#Y^HGPI0GD9ON1ZP_+<M_V7G3YUM9Z#^G:B!7&\X5K@W='U
M;5-F /'<&JW51T-F^-&WF_NZ\M+;]^IH^;;S,E34OK(W6*4C>?1E<$=47DX[
M1ATDW_96W'"[7<93*B9PRD/=8FUYD17[=>3\W$.Y34%-<!S^JN3"3''>GU%Q
MX@M+!T*4E^.+MAW._V ;Y2K:2\T]%MC7<=='[(=]N11+_@%02P$"% ,4
M"  "@2I/>]1Q23,1  "=?@  #@              @ $     9#<V-30Y-F0X
M:RYH=&U02P$"% ,4    "  "@2I/#W8,G9&7  " *@, $
M@ %?$0  9#<V-30Y-F1E>#$Q+FAT;5!+ 0(4 Q0    (  *!*D]S!M%?D@L
M &TG   0              "  1ZI  !D-S8U-#DV9&5X-3$N:'1M4$L! A0#
M%     @  H$J3Q4')DUF P  +PP  !$              ( !WK0  &ER=&,M
M,C Q.3 Y,#4N>'-D4$L! A0#%     @  H$J3Q8BG$B!!@  24<  !4
M         ( !<[@  &ER=&,M,C Q.3 Y,#5?;&%B+GAM;%!+ 0(4 Q0    (
M  *!*D]X;9MMR 0  -4L   5              "  2>_  !I<G1C+3(P,3DP
A.3 U7W!R92YX;6Q02P4&      8 !@!] 0  (L0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
